phosphonoacetic acid has been researched along with foscarnet in 414 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 222 (53.62) | 18.7374 |
| 1990's | 190 (45.89) | 18.2507 |
| 2000's | 1 (0.24) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (0.24) | 2.80 |
| Authors | Studies |
|---|---|
| Duncan, IB; Hall, MJ; Heimer, EP; Lambert, RW; Martin, JA; Thomas, GJ | 1 |
| De Clercq, E; Griengl, H; Hayden, W; Penn, G; Rosenwirth, B | 1 |
| Oberg, B; Sundquist, B | 1 |
| Healy, B | 1 |
| Hirsch, MS | 1 |
| Masur, H | 1 |
| Heinemann, MH | 1 |
| Polis, MA | 2 |
| Jacobson, MA | 3 |
| Jabs, DA | 1 |
| Coen, DM; Hwang, CB; Ruffner, KL | 1 |
| Frissen, PH; Jansen, CL; Maris-Tegeler, WG; van der Noordaa, J; Weiland, HT; Wertheim-van Dillen, PM | 1 |
| Butler, KM; De Smet, MD; Husson, RN; Jarosinski, P; Lovato, G; Manjunath, K; Montrella, K; Mueller, B; Nussenblatt, RB; Pizzo, PA | 1 |
| Salit, IE | 1 |
| Evans, JK; Miller, RF; Scoular, A | 1 |
| Drew, WL | 1 |
| Chave, B; Dhiver, C; Gastaut, JA; Gastaut, JL; Nicoli, F; Poizot-Martin, I | 1 |
| Cerrina, J; Le Roy Ladurie, F | 1 |
| Wilson, RJ | 1 |
| Otová, B; Roubínek, F; Smejkal, F; Zikán, V | 1 |
| Skolnik, PR | 1 |
| Deray, G; Jacobs, C; Katlama, C | 1 |
| Bachman, DM | 1 |
| Peters, M; Pohle, HD; Ruf, B; Schürmann, D; Timm, U | 1 |
| Brancon, C; Caumes, E; Cochereau-Massin, I; Dahan, R; Dohin, E; Gentilini, M; Katlama, C; Robinet, M; Rogeaux, O | 1 |
| Blanshard, C | 2 |
| Balfour, HH; Drew, WL; Hardy, WD; Heinemann, MH; Polsky, B | 1 |
| Connolly, S; Malin, A; Manji, H | 1 |
| Birch, CJ; Doherty, R; Hayes, K; Lucas, CR; Mijch, A; Tachedjian, G; Tyssen, DP | 1 |
| Harvey, N; Tenenhouse, HS | 1 |
| Evans, LM; Grossman, ME | 1 |
| Cotte, L; Langlois, M; Trepo, C | 1 |
| Aschan, J; Ljungman, P; Lönnqvist, B; Ohlman, S; Ringdén, O | 1 |
| Blyth, WA; Hill, TJ; Rogers, CE; Yirrell, DL | 2 |
| Gambertoglio, JG; Lilleby, K; Meyers, JD; Reusser, P | 1 |
| Causey, DM; Davis, RB; Grieco, MH; Hooton, TM; Jacobson, MA; McKinley, GF; Parenti, DM; Reddy, MM; van der Horst, CM | 1 |
| Coen, DM; Hicks, KA; Pelosi, E; Sacks, SL | 1 |
| Jacobson, PA; Levinson, ML | 1 |
| Gazzard, BG; Harman, C; Mathalone, B; Mitchell, S; Moyle, G | 1 |
| Bedos, JP; Rogeaux, O; Vachon, F; Wolf, M | 1 |
| Lurain, NS; Tatarowicz, WA; Thompson, KD | 1 |
| Morris, DJ | 1 |
| Wood, CA | 1 |
| de Gans, J; Enting, R; Jansen, C; Portegies, P; Reiss, P | 1 |
| Anzai, H; Hara, O; Hidaka, T; Imai, S; Murakami, T; Nagaoka, K; Seto, H | 1 |
| Deibel, MR; Dueweke, TJ; Kézdy, FJ; Tarpley, WG; Waszak, GA | 1 |
| Crumpacker, CS | 1 |
| Lietman, PS | 1 |
| Cheng, YC; Dutschman, GE; Im, GJ; Mellors, JW; Tramontano, E; Winkler, SR | 1 |
| Cheng, YC; Tramontano, E | 1 |
| Burrell, CJ; Kuiper, LJ; Li, P; Stephenson, AJ | 1 |
| Dousa, TP; Loghman-Adham, M | 1 |
| Chen, ZJ; Liu, WG; Song, JZ | 1 |
| Conley, SR; Dembo, M; Gelderblom, HR; Layne, SP; Merges, MJ; Moore, JP; Nara, PL; Raina, JL; Renz, H; Spouge, JL | 1 |
| Brettle, R; Willocks, L | 1 |
| Bai, SA; de Vera, CC; Loo, TL; Nelson, PD; Straw, JA; Tompkins, WA | 1 |
| David, F; Gerrier, F; Kateb, M; Modai, J; Molina, JM; Morinet, F; Schnell, L; Scieux, C | 1 |
| Dousa, TP; Loghman-Adham, M; Szczepanska-Konkel, M | 1 |
| Hardy, WD | 1 |
| al-Mahrouq, HA; Kempson, SA | 2 |
| Van der Pijl, JW | 1 |
| Loghman-Adham, M | 1 |
| Ljungdahl-Ståhle, E; Oberg, B; Trojnar, J; Wahren, B | 1 |
| Seigneurin, JM | 1 |
| Bardini, J; Caliendo, G; Cohen, H; el-Chaar, GM; Frank, C; Profeta, LM; Schwenk, MH; Talbot, KA | 1 |
| Cox, SW; Wahren, B | 1 |
| Lundström, J; Nordgren, T; Ryrfeldt, A | 1 |
| Gazzard, BG | 1 |
| Leport, C; Longuet, P | 1 |
| Lacey, HB; Mandal, BK; Ness, A | 1 |
| DiStefano, JE; Outman, WR | 1 |
| Drew, WL; Feinberg, J; Jacobson, MA; Miner, RD; O'Donnell, JJ; Parenti, D; Whitmore, PV | 1 |
| Berger, TG; Biron, KK; Gilson, I; Mills, J; Safrin, S; Wofsy, CB; Wolfe, PR | 1 |
| Petersen, EA | 1 |
| Reed, EC | 1 |
| Connolly, GM; Gazzard, BG; Hawkins, DA; Nelson, MR | 1 |
| Angritt, P; Davis, C; James, WD; Kahlter, DC; Skelton, HG; Smith, KJ | 1 |
| Charpentier, B | 1 |
| Ehlin-Henriksson, B; Ernberg, I; Falk, K; Klein, G; Minarovits, J; Minarovits-Kormuta, S | 1 |
| Chatis, P; Crumpacker, C; Davis, R; Hafner, R; Kessler, HA; Landry, B; Mills, J; Rush, J; Safrin, S | 1 |
| Ash, RC; Carrigan, DR; Drobyski, WR; Knox, KK | 1 |
| Coen, DM; Sullivan, V | 1 |
| Gambertoglio, JG; Graziani, AL; Grunwald, JE; MacGregor, RR; Weiss, R | 1 |
| Harvengt, C | 1 |
| Baird, BF; Davey, RT; Davis, M; De Smet, MD; Falloon, J; Kovacs, JA; Palestine, AG; Polis, MA; Zunich, KM; Zurlo, JJ | 1 |
| Marwick, C | 1 |
| Degré, M | 1 |
| Bruun, JN; Moeland, A | 1 |
| Borysiewicz, LK; Gray, JJ; Higenbottam, TW; Scott, JP; Sharples, LD; Smyth, RL; Stewart, S; Wallwork, J; Wreghitt, TG | 1 |
| Nightingale, SL | 1 |
| Minor, JR | 1 |
| Anderson, S; Beck, EJ; Coker, R; Coleman, D; Harris, JR; Main, J; Migdal, C; Peters, BS; Pinching, AJ | 1 |
| Deneux, C; Durand, H; Fadlallah, JP; Haas, C; Lowenstein, W; Roudière, L | 1 |
| Bacchetti, P; Harb, GE; Jacobson, MA | 1 |
| Ayisi, NK; Gupta, SV; Qualtiere, LF | 1 |
| Gaballo, A; Gerna, G; Milanesi, G; Parea, M; Percivalle, E; Zavattoni, M; Zipeto, D | 1 |
| Gümbel, H; Helm, EB; Ohrloff, C; Schalnus, R | 1 |
| De Clercq, E; Himpens, B; Neyts, J; Schols, D; Snoeck, R | 1 |
| Jenkins, RE; Peters, BS; Pinching, AJ | 1 |
| Carrigan, DR; Drobyski, WR; Knox, KK | 1 |
| Barter, G; Gazzard, BG; Hawkins, D; Nelson, MR | 1 |
| Coker, RJ; Harris, JR; Horner, P; Migdal, C; Tomlinson, D | 1 |
| Griffiths, PD | 1 |
| Chrisp, P; Clissold, SP | 1 |
| Kemp, SD; Larder, BA; Lowe, DM; Parmar, V | 1 |
| Quan, K; Tao, P; Zhang, X | 1 |
| Cox, S; Harmenberg, J; Koshida, R; Wahren, B | 1 |
| Friberg, TR; Leeper, HF; Paul, AA | 1 |
| Bratt, G; Grützmeier, S; Rieger, A; Sandström, E; Sjunnesson, M; Söderlund, C | 1 |
| Armstrong, D; Chou, TC; Gold, JW; Kong, XB; Polsky, B; Ruprecht, RM; Watanabe, KA; Zeidler, JM; Zhu, QY | 1 |
| Cersosimo, RJ; Matthews, SJ; Spivack, ML | 1 |
| Cheney, CM; Kociba, GJ; Mathes, LE; Polas, PJ; Swenson, CL | 1 |
| Epstein, JB | 1 |
| Choi, SS; Rasshofer, R; Roggendorf, M; Wölfl, P | 1 |
| Hansson, BG; Nordenfelt, E; Riesbeck, K; Weiland, O | 1 |
| Arbesfeld, DM; Thomas, I | 1 |
| Aweeka, FT; Causey, DM; Gambertoglio, JG; Jacobson, MA; Portale, AA | 1 |
| East, JM; Lee, AG; Stefanova, HI | 1 |
| Bratzke, B; Ehlers, G; Orfanos, CE; Stavermann, T | 1 |
| Causey, DM; Dehlinger, M; Hafner, R; Jacobsen, MA; Mills, J; van der Horst, C | 1 |
| Albrecht, H; Greten, H; Löning, T; Stellbrink, HJ | 1 |
| Dousa, TP; Hoppe, A; Knox, FG; Lin, JT; Onsgard, M | 1 |
| Hayes, KA; Mathes, LE; Nagode, LA; Steinmeyer, CL; Swenson, CL; Weisbrode, SE | 1 |
| Caracatsanis, M; Fouda, N; Hammarström, L; Kut, IA | 1 |
| Harvey, N; Lee, J; Tenenhouse, HS | 1 |
| Bevilacqua, F; Cusini, M; Gerna, G; Marcello, A; Palù, G; Toni, M; Zavattoni, M; Zerboni, R | 1 |
| Béliveau, R; Delisle, MC; Laprade, R; Vachon, V | 1 |
| Bonjour, JP; Caverzasio, J; Montessuit, C | 1 |
| Bouffard, L; Dubé, J; Plante, GE; Sirois, P | 1 |
| Jacobson, MA; O'Donnell, JJ | 2 |
| Henderly, DE; Jampol, LM | 1 |
| Baltz, JK; Minor, JR | 1 |
| Coen, DM; Malick, A; Markert, JM; Martuza, RL; Ruffner, KL | 1 |
| Bakker-Woudenberg, IA; Lokerse, AF; ten Kate, M | 1 |
| Danner, SA; Frissen, PH; Hulsebosch, HJ; Lange, JM; Reiss, P; Van Den Tweel, JG; Van Der Pijl, JW | 1 |
| Gilquin, J; Kazatchkine, MD; Weiss, L | 1 |
| Beaufils, H; Deray, G; Dohin, E; Henin, D; Jouanneau, C; Katlama, C; Sazdovitch, V | 1 |
| Aubertin, P; Barrier, JH; Boibieux, A; Lortholary, A; Peyramond, D; Raffi, F | 1 |
| Lor, E; Takagi, J | 1 |
| Blohmé, I; Nyberg, G; Persson, H; Svalander, C | 2 |
| Aweeka, FT; Gambertoglio, JG; Hassanzadeh, MK; Jacobson, MA; Wu, S | 1 |
| Levi, M | 1 |
| Mathes, LE; Michael, DF; Polas, PJ; Sams, RA; Swenson, CL | 1 |
| Cossart, YE; Freiman, JS; Lim, D; Murray, SM; Vickery, K | 1 |
| Lee, J; Tenenhouse, HS | 1 |
| Beliveau, R; Harvey, N; Jette, M; Lee, J; Potier, M; Tenenhouse, HS | 1 |
| Bhongle, NN; Camaioni Neto, C; Piratla, RK; Sarin, PS; Steim, JM; Sun, DK; Turcotte, JG | 1 |
| Baltz, JK; Gallelli, J; Kennedy, P; Minor, JR | 1 |
| Béliveau, R; Demeule, M; Jetté, M; Lee, J; Potier, M; Tenenhouse, HS | 1 |
| Goldberg, DJ; Green, ST; Kennedy, DH; Mack, DJ; Nathwani, D | 1 |
| Genovesi, EV; Gerstner, DJ; Knudsen, RC; Villinger, F; Whyard, TC | 1 |
| Seyffert, C; Spitzbart, H; Thust, U | 1 |
| Charmot, G; Coulaud, JP; De Truchis, P; Fegueux, S; Ingrand, D; Kernbaum, S; Simon, F | 1 |
| Bose, RN; Slavin, LL | 1 |
| Chanas, A; Gazzard, B; Youle, M | 1 |
| Leport, C; Salmon, D | 1 |
| Benson, M; Chew, E; Fanning, MM; Harvey, P; Kozousek, V; Mortimer, C; Rachlis, A; Read, SE; Schwartz, C; Vas, S | 1 |
| Lane, HC; Manischewitz, JF; Quinnan, GV; Wittek, AE | 1 |
| Cronin, RE; Levi, M | 1 |
| Farese, RV; Hollander, H; Jacobson, MA; Schambelan, M; Stringari, S | 1 |
| Connolly, GM; Gazzard, BG; Hawkins, DA | 1 |
| Assaykeen, T; Follansbee, S; Mills, J; Safrin, S | 1 |
| Charles, SJ; Gray, JJ | 1 |
| Ellis, MN; Hackman, RC; Ljungman, P; Meyers, JD; Shepp, DH | 1 |
| Deray, G; Dohin, E; Katlama, C | 1 |
| Birch, CJ; Doherty, RR; Gust, ID; Hayes, K; Tachedjian, G | 1 |
| Balzarini, J; Bron, D; De Clercq, E; Delforge, A; Lagneaux, L; Snoeck, R; Stryckmans, P; Van der Auwera, P | 1 |
| Cotton, P | 1 |
| Akerlund, B; Aman, P; Carenfelt, C; Gustavsson, E; Klein, E; Klein, G; Lejdeborn, L; Lewin, N | 1 |
| Byington, RE; Hirsch, MS; Kaplan, JC; Sandstrom, EG | 1 |
| Hirsch, MS; Kaplan, JC | 1 |
| Gallo, RC; Oberg, B; Sarin, PS; Sun, D; Taguchi, Y; Thornton, A | 1 |
| Oberg, B; Vrang, L | 1 |
| De Clercq, E | 1 |
| Hirsch, MS; Schooley, RT; Vogt, M | 1 |
| Katinka, MD | 1 |
| Frank, KB; McKernan, PA; Smee, DF; Smith, RA | 1 |
| Pomerantz, RJ; Schooley, RT | 1 |
| Meyers, JD; Reed, EC | 1 |
| Bryson, YJ | 1 |
| Kurth, R; Löwer, J; Wondrak, EM | 1 |
| Darby, G; Larder, BA; Richman, DD | 1 |
| Mitchell, WM; Montefiori, DC; Robinson, WE | 1 |
| Kemp, SD; Larder, BA; Purifoy, DJ | 1 |
| Kurth, R; Löwer, J; Oberg, B; Vrang, L | 1 |
| Cheng, YC; Starnes, MC | 1 |
| Löfgren, B; Nordenfelt, E; Oberg, B | 1 |
| Andersson, J; Ericzon, BG; Hultcrantz, R; Stiernstedt, G; Weiland, O | 1 |
| Drennan, DP; Erlich, KS; Follansbee, SE; Gooze, L; Jacobson, MA; Koehler, JE; Mills, J; Safrin, S | 1 |
| Tamai, I; Tsuji, A | 1 |
| Caracatsanis, M; Fouda, N; Hammarström, L | 1 |
| Hussain, AS; Ritschel, WA | 2 |
| Dousa, TP; Hoppe, A; Szczepanska-Konkel, M; Yusufi, AN | 1 |
| Datema, R; Ekström, C; Strid, S | 1 |
| Drennan, DP; Greenspan, D; MacPhail, LA; Mills, J; Schiødt, M | 1 |
| Dousa, TP; Moltaji, H; Yusufi, AN | 1 |
| Nordgren, T; Pettersson, KJ; Westerlund, D | 1 |
| Gilljam, G; Harmenberg, J; Koshida, R; Oberg, B; Vrang, L; Wahren, B | 1 |
| Klugerman, AH; Neal, JL; Tenenhouse, HS | 1 |
| Bergdahl, S; Movin, G; Ogenstad, S; Saarimäki, M; Sjövall, J | 1 |
| Alexander, GJ; Bain, VG; Chanas, A; Daniels, HM; Williams, R | 1 |
| Crowe, SM; Elbeik, T; Kirihara, J; McGrath, MS; Mills, J | 1 |
| Cox, S; Gilljam, G; Harmenberg, J; Koshida, R; Wahren, B | 1 |
| Chatis, PA; Crumpacker, CS; Miller, CH; Schrager, LE | 1 |
| Azuma, M; Sakuma, T | 1 |
| Chiba, S | 1 |
| Oberg, B | 2 |
| Girard, B; Katlama, C; Lehoang, P; Lernestedt, JO; Marcel, P; Matheron, S; Morer, I; Robinet, M; Rozenbaum, W; Zazoun, L | 1 |
| Eriksson, BF; Schinazi, RF | 1 |
| Jacobson, MA; Mills, J; O'Donnell, JJ | 1 |
| Aweeka, F; Gambertoglio, J; Jacobson, MA; Mills, J | 1 |
| Pinching, AJ | 1 |
| Carroll, RD; Haffey, ML; Matthews, JT; Stevens, JT | 1 |
| Baumelou, A; Beaufils, H; Danis, M; Deray, G; Dohin, E; Gentilini, M; Katlama, C; Levaltier, B; Martinez, F; Rozenheim, M | 1 |
| Aschan, J; Lonnqvist, B; Ringden, O; Sundberg, B | 1 |
| Akesson-Johansson, A; Andersson, J; Brattström, C | 1 |
| Fraser-Smith, EB; Freitas, VR; Matthews, TR | 1 |
| Frazer, I; Hogan, P; Whitby, M; Wood, G | 1 |
| Agut, H; Collandre, H; Huraux, JM; Montagnier, L | 1 |
| Kaplan, JC; Sandström, EG | 1 |
| Anders, DG; Gibson, W; Kidd, JR | 1 |
| Acheson, JF; Bradbeer, C; Shah, SM; Spalton, DJ; Thin, RN | 1 |
| Brunette, EN; DeBruin, M; Debs, RJ; Montgomery, AB; Shanley, JD | 1 |
| Helbig, B; Herrmann, G; Klöcking, R; Sauerbrei, A; Wicht, N; Wiedemann, U; Wutzler, P | 1 |
| Chew, E; Fanning, MM; Rachlis, A; Read, SE; Salit, I; Vellend, H; Walmsley, SL | 1 |
| Jacobson, MA; Mills, J | 1 |
| Akesson-Johansson, A | 1 |
| Datema, R; Ericson, AC; Kristofferson, A; Sohl-Akerlund, A | 1 |
| Baumelou, A; Cacoub, P; Deray, G; Gentilini, M; Jacobs, C; Le Hoang, P; Rousselie, R; Rozenbaum, W; Soubrie, C | 1 |
| Broder, S; Yarchoan, R | 1 |
| Meyers, JD | 1 |
| Chu, CJ; Szoka, FC | 1 |
| Akesson-Johansson, A; Lernestedt, JO; Lönnqvist, B; Ringdén, O; Wahren, B | 1 |
| Aweeka, F; Crowe, S; Gambertoglio, J; Jacobson, MA; Levy, J; McManus, N; Mills, J | 1 |
| Gonzales, MF; Greco, C; Jacobson, MA; Miller, RG; Mills, J; O'Donnell, JJ; Rush, J | 1 |
| Gibson, W; Irmiere, A; Lee, JY | 1 |
| Dousa, TP; Homma, S; Knox, FG; Loghman-Adham, M; Onsgard, M; Szczepanska-Konkel, M; VanScoy, M | 1 |
| Bloom, JN; Palestine, AG | 1 |
| Arthur, C; Ganly, PS; Goldman, JM; Schulenburg, WE | 1 |
| Wyngaarden, JB | 1 |
| Cheng, YC; Li, JS | 1 |
| Richman, DD | 1 |
| Girard, PM; Le Hoang, P; Michon, C; Ngovan, P; Simonpoli, AM | 1 |
| Akerfeldt, S; Bergman, J; Harmenberg, J; Lundblad, L; Wahren, B | 1 |
| Herrmann, G; Reefschläger, J; Thiel, KD; Wutzler, P | 2 |
| Al-Samarai, A; Kinghorn, G; Potter, C | 1 |
| Apperley, JF; Chanas, A; Goldman, JM; Gravett, PJ; Marcus, RE; Wardle, DG | 1 |
| Gahrton, G; Lernestedt, JO; Lönnqvist, B; Ringdén, O; Wahren, B; Wilczek, H | 1 |
| Beldekas, JC; Black, P; Levy, EM; Sandstrom, E; Von Krogh, G | 1 |
| Färber, I; Ulbricht, A; Wutzler, P | 1 |
| France, AJ; Moaven, LD; Price, JS; Welsby, PD | 1 |
| Baumelou, A; Cacoub, P; Deray, G; Jacobs, C; Le Hoang, P; Morer, I; Rousselie, F; Soubrie, C | 1 |
| Bergdahl, S; Larsson, A; Sönnerborg, A; Strannegard, O | 1 |
| Chanas, A; Clarbour, J; Gazzard, B; Youle, MS | 1 |
| Collins, P; Evans, R; Hawkins, DA; Lawrence, A; Oliver, N; Shanson, DC; Youle, MM | 1 |
| Harmenberg, JG; Svensson, LT | 1 |
| Heley, A | 1 |
| Buck, CC; Loh, PC | 1 |
| Skog, S; Stenberg, K; Tribukait, B | 2 |
| Albert, DA; Gudas, LJ | 2 |
| Sandström, E | 1 |
| Barton, SE; Essex-Cater, AJ; Kinghorn, GR; Kuijpers, MH; Munday, PE; Notowicz, A; Rashid, S; Schuller, JL; Stolz, E; van der Meijden, WI | 1 |
| Hirota, K; Okuda, K; Omata, M; Sherker, AH | 1 |
| Freeman, DJ; Sheth, NV; Spruance, SL | 1 |
| Dousa, TP; Kempson, SA; McAteer, JA; Szczepanska-Konkel, M; Yusufi, AN | 1 |
| Bird, RM; Broadhurst, AV; Duncan, IB; Hall, MJ; Lambert, RW; Wong-Kai-In, P | 1 |
| Aoki, FY; Bright, C; Kaluski, J; Lawee, D; Poisson, M; Portnoy, J; Sacks, SL; Schlech, W; Tyrrell, DL | 1 |
| Howkins, GJ; Hunt, AF; Jones, MT | 1 |
| Dousa, TP; Loghman-Adham, M; Szczepanska-Konkel, M; Van Scoy, M; Yusufi, AN | 1 |
| Weber, J | 1 |
| Doraisingham, S; Lee, CT; Lim, KB; Ling, AE; Tan, T; Thirumoorthy, T | 1 |
| Dousa, TP; Szczepanska-Konkel, M; Yusufi, AN | 1 |
| Collins, P; Tsiquaye, KN; Zuckerman, AJ | 1 |
| Boogaerts, M; De Clerck, D; De Clercq, E; Vinckier, F | 1 |
| Hansson, BG; Hedin, G; Ljunggren, K; Nordenfelt, E; Oberg, B; Strömberg, A; Weiland, O | 1 |
| Douglas, R | 1 |
| Ariens, AT; Datema, R; Ericson, AC; van Genderen, J; Wolthuis, OL | 1 |
| Chanas, A; Clark, A; Dalgleish, AG; Farthing, CF; Gazzard, BG; McClure, M | 1 |
| Faber, V; Gaub, J; Gerstoft, J; Hofmann, B; Lernestedt, JO; Lindhardt, BO; Mathiesen, LR; Pedersen, C; Poulsen, AG; Ulrich, K | 1 |
| Aoki, FY; Lawee, D; Portnoy, J; Rosenthal, D | 1 |
| Attanasio, R; Johnson, JC | 1 |
| Karlsson, A; Ogenstad, S; Saarimäki, M; Sandström, E; Sjövall, J | 1 |
| Ablashi, DV; Fullen, J; Hellman, K; Hung, CL; Salahuddin, SZ; Saxinger, C; Streicher, HZ | 1 |
| Peyman, GA; Schulman, JA; She, SC | 1 |
| Coen, DM; Fleming, HE; Leslie, LK; Retondo, MJ | 1 |
| Fong, CK; Hsiung, GD; Mayo, DR; Winship, T; Zheng, ZM | 1 |
| Dolin, R | 1 |
| Allaudeen, HS | 1 |
| Ayisi, NK; Babiuk, LA; Gupta, SV | 1 |
| Cheng, YC; Frank, KB | 2 |
| Harmenberg, J; Levén, B; Sundqvist, VA; Wahren, B | 1 |
| Gahrton, G; Groth, CG; Klintmalm, G; Lernestedt, JO; Lönnqvist, B; Lundgren, G; Oberg, B; Ringdén, O; Robert, KH; Wahren, B | 1 |
| Cheng, YC; Chiou, JF; Li, JK | 1 |
| Glaser, R; Holliday, J; Williams, MV | 1 |
| Cohen, J; Fallon, TJ; Schulenburg, WE; Singer, DR; Williams, G | 1 |
| Eriksson, B; Gadler, H; Oberg, B; Rudén, U; Wahren, B | 1 |
| Ahlmén, J; Brynger, H; Lycke, E; Wijnween, AC | 1 |
| Ahlmén, J; Klintmalm, G; Lernestedt, JO; Lönnqvist, B; Paulin, T; Ringdén, O; Wahren, B | 1 |
| Dousa, TP; Szczepanska-Konkel, M; VanScoy, M; Webster, SK; Yusufi, AN | 1 |
| Anders, DG; Gibson, W; Irmiere, A | 1 |
| Bornkamm, GW; Daillie, J; Decaussin, G; Lenoir, GM; Ooka, T | 1 |
| Frödin, L; Gronowitz, JS; Källander, CF; Larson, A; Larsson, E; Tufveson, G | 1 |
| Cheng, YC; Chiou, JF; Frank, KB | 1 |
| Claesson, K; Frödin, L; Gronowitz, JS; Källander, CF; Larsson, A; Lernestedt, JO; Sjöberg, O; Tufveson, G | 1 |
| McKernan, PA; Robins, RK; Vaghefi, MM | 1 |
| Chou, TC; Hartshorn, KL; Hirsch, MS; Neumeyer, D; Paradis, TJ; Sandstrom, EG; Schooley, RT | 1 |
| Brännström, G; Gadler, H; Harmenberg, J; Levén, B; Sundqvist, VA; Wahren, B | 1 |
| Hall, MJ | 1 |
| Boissonnas, A; Brochard, L; Duroux, P; Herve, P; Petitpretz, P; Salmeron, S; Simonneau, G | 1 |
| Aman, P; Henle, G; Henle, W; Klein, E; Klein, G; Lewin, N; Masucci, MG; Oberg, B; Strander, H | 1 |
| Barrison, I; Boylston, A; Forster, S; Jeffries, DJ; Pinching, AJ; Thom, S; Unwin, R; Weber, JN | 1 |
| Clarke, JR; Davis, JM; Jeffries, DJ; Tyms, AS | 1 |
| Bombail, D; Cavazzana, M; De Castro, H; Gluckman, E; Huart, JJ; Jolivet, I; Keable, H; Meletis, J; Nebout, T | 1 |
| Anderson, MG; Chanas, AC; Ellis, ME; Farthing, C; Gazzard, BG | 1 |
| Grummich, KW; Hussain, SA; Ritschel, WA | 1 |
| Abele, G; Harmenberg, J; Wahren, B | 1 |
| Lernestedt, JO; Lycke, E; Ogenstad, S; Wallin, J | 1 |
| Poryo, A; Wigand, R | 1 |
| Matz, B; Schlehofer, JR; zur Hausen, H | 1 |
| Brichácek, B; Prachová, K; Reifová, M; Roubal, J; Vonka, V | 1 |
| Lehtinen, MO; Lehtinen, TK; Leinikki, PO | 1 |
| Nicholson, KG | 1 |
| Gillerman, E; Modak, MJ; Srivastava, A | 1 |
| Banerjee, AK; Chanda, PK | 1 |
| Nordlund, S; Robèrt, KH; Wahren, B | 1 |
| Falk, H; Margalith, M; Panet, A | 1 |
| Kelley, E; Spector, SA; Tyndall, M | 2 |
| Eriksson, B; Oberg, B; Stening, G | 1 |
| Cox, GS; Park, KH | 1 |
| Janz, C; Wigand, R | 1 |
| Burkhardt, U; Wigand, R | 1 |
| Arens, M; Goto, Y; Hashimoto, T; Takahashi, T; Yamashita, T | 1 |
| Brochier, B; Pastoret, PP; Schwers, A; Thiry, E; Vindevogel, H; Wérenne, J | 1 |
| Friedman-Kien, AE; Klein, RJ | 1 |
| Hansson, BG; Löfgren, B; Möller-Nielsen, C; Nordenfelt, E; Oberg, B; Widell, A | 1 |
| Chak, W; Kwan, JP; Lin, HJ; Wu, PC | 1 |
| Chak, W; Lai, CL; Lin, HJ; Wu, PC | 1 |
| Hantz, O; Ooka, T; Pichoud, C; Trepo, C; Vitvitski, L | 1 |
| Datema, R; Stridh, S | 1 |
| Lycke, E; Svennerholm, B; Ziegler, R | 1 |
| Muratore, O; Raffanti, SP; Schito, GC; Varnier, OE | 1 |
| Ahlmén, J; Blohmé, I; Brynger, H; Jeansson, S; Ranch, T | 1 |
| Hsiung, GD; Mayo, DR | 1 |
| Imai, S; Inouye, S; Niida, T; Ogawa, H; Otake, N; Sasaki, T; Satoh, A; Seto, H; Tsuruoka, T | 1 |
| Oberg, B; Wahren, B | 2 |
| Goldblum, N; Manor, D; Margalith, M; Usieli, V | 1 |
| Alenius, S; Laurent, U; Oberg, B | 1 |
| Alenius, S | 1 |
| Caradonna, SJ; Chen, JY; Cheng, YC; Connor, K; Derse, D; Grill, S | 1 |
| Darby, G; Field, H; McMillan, A | 1 |
| Oberg, B; Schnürer, J | 1 |
| Aguilar-Setien, A; Godart, M; Leroy, P; Pastoret, PP; Schwers, A; Vindevogel, H | 1 |
| Datta, AK; Hood, RE | 1 |
| Lycke, E; Svennerholm, B; Vahlne, A | 1 |
| Oxford, JS | 1 |
| Nilheden, E; Svennerholm, B; Vahlne, A | 1 |
| Alenius, S; Berg, M; Broberg, F; Eklind, K; Lindborg, B; Oberg, B | 1 |
| Glasgow, LA; Kern, ER; Overall, JC; Richards, JT | 1 |
| Fanta, D | 1 |
| Sallis, JD; Williams, G | 1 |
| Aguilar-Setien, A; Pastoret, PP; Vindevogel, H | 1 |
| Klein, RJ | 1 |
| Nahmias, AJ; Schinazi, RF | 1 |
| Bastow, KF; Cheng, Y; Derse, D | 1 |
| Bertram, D; Sprössig, M; Thiel, KD; Wutzler, P | 1 |
| Cheriyan, UO; Galloway, KS; Ogilvie, KK; Smith, KO | 1 |
| Hsiung, GD; Lucia, HL; Mayo, DR | 1 |
| Helgstrand, E; Johansson, NG; Misiorny, A; Norén, JO; Stening, G | 1 |
| Bastow, KF; Cheng, YC; Derse, DD | 1 |
| Larsson, A; Oberg, B; Wrååk, M | 1 |
| Griffith, BP; Hsiung, GD; Lucia, HL | 1 |
| Baba, M; De Clercq, E; Ito, M; Shigeta, S | 1 |
| Oxford, J | 1 |
| Nordenfelt, E; Werner, B | 1 |
| Goodrich, JM; Hinze, HC; Lee, KW | 1 |
| Arnold, W; Hess, G; Meyer zum Büschenfelde, KH | 1 |
| Arnold, W; Hess, G; Hütteroth, TH; Meyer zum Büschenfelde, KH | 1 |
| Li, YY; Minagawa, H; Mori, R; Tanaka, S | 1 |
| Bailey, JM; Lightfoote, M; Lillehoj, E; Nelson, K | 1 |
| Camplo, M; Charvet, AS; Chermann, JC; Faury, P; Graciet, JC; Kraus, JL; Mourier, N | 1 |
| Nonay, RL; Reha-Krantz, LJ; Stocki, S | 1 |
| Aldern, KA; Barshak, L; Beadle, JR; Border, R; Gardner, MF; Hostetler, KY; Kini, GD; Kumar, R; Richman, DD; Sridhar, CN; Wheeler, CJ | 1 |
| Andrei, G; De Clercq, E; Snoeck, R | 1 |
| Flore, O; Gao, SJ | 1 |
| Mezna, M; Michelangeli, F | 1 |
| Bocharov, EV; Fedyuk, NV; Ivanov, AV; Jasko, MV; Khandazhinskaya, AL; Kukhanova, MK; Mitkevich, VA; Pokrovsky, AG; Pronyaeva, TR; Shirokova, EA; Skoblov, YS; Yanvarev, DV | 1 |
| Caruthers, MH; Kumar, P | 1 |
49 review(s) available for phosphonoacetic acid and foscarnet
| Article | Year |
|---|---|
Characteristics of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retina; Retinitis | 1992 |
Maintenance therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: foscarnet.
Topics: Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis | 1992 |
Cytomegalovirus infection in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Chorioretinitis; Cytomegalovirus Infections; Encephalitis; Foscarnet; Ganciclovir; Gastroenteritis; Humans; Phosphonoacetic Acid; Pneumonia, Viral | 1992 |
[Cytomegalovirus infection in patients after lung transplantation].
Topics: Acyclovir; Antiviral Agents; Blood Transfusion; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immune Tolerance; Incidence; Lung Transplantation; Phosphonoacetic Acid; Prevalence; Viral Vaccines | 1992 |
Cytomegalovirus retinitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Diagnosis, Differential; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis | 1992 |
Combined and alternating ganciclovir and foscarnet in acute and maintenance therapy of human immunodeficiency virus-related cytomegalovirus encephalitis refractory to ganciclovir alone. A case report and review of the literature.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Administration Schedule; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Male; Meningitis, Viral; Phosphonoacetic Acid | 1992 |
Foscarnet and ganciclovir in the treatment of cytomegalovirus retinitis.
Topics: Cytomegalovirus Infections; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis | 1992 |
Foscarnet therapy for AIDS-related opportunistic herpesvirus infections.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Herpesviridae Infections; HIV Infections; Humans; Opportunistic Infections; Phosphonoacetic Acid | 1992 |
Foscarnet-induced penile ulcer.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Humans; Male; Penile Diseases; Phosphonoacetic Acid; Retinitis; Skin Ulcer | 1992 |
Treatment and prophylaxis of cytomegalovirus disease.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Gastroenteritis; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Phosphonoacetic Acid; Pneumonia, Viral; Retinitis | 1992 |
Mechanism of action of foscarnet against viral polymerases.
Topics: Antiviral Agents; DNA-Directed RNA Polymerases; Drug Interactions; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Herpesviridae; HIV; HIV Reverse Transcriptase; Humans; Nucleic Acid Synthesis Inhibitors; Phosphonoacetic Acid; Reverse Transcriptase Inhibitors; Simplexvirus | 1992 |
Clinical pharmacology: foscarnet.
Topics: Antiviral Agents; Foscarnet; HIV; Humans; Nucleic Acid Synthesis Inhibitors; Phosphonoacetic Acid; Reverse Transcriptase Inhibitors | 1992 |
New drugs on the horizon.
Topics: Acquired Immunodeficiency Syndrome; Aminosalicylic Acids; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiemetics; Antineoplastic Agents; Antiviral Agents; Cardiovascular Agents; Dose-Response Relationship, Drug; Drug Interactions; Foscarnet; Hematinics; Humans; Imidazoles; Ofloxacin; Ondansetron; Pharmaceutical Preparations; Phosphonoacetic Acid; Serotonin Antagonists | 1992 |
Foscarnet therapy in persons with AIDS: clinical research and management considerations. Introduction.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Drug Administration Schedule; Foscarnet; Humans; Phosphonoacetic Acid | 1992 |
Review of the toxicities of foscarnet.
Topics: Antiviral Agents; Foscarnet; Humans; Phosphonoacetic Acid | 1992 |
[Prophylactic treatments of opportunistic infections in acquired immunodeficiency syndrome].
Topics: Acquired Immunodeficiency Syndrome; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Male; Opportunistic Infections; Pentamidine; Phosphonoacetic Acid; Pneumonia, Pneumocystis; Sulfadiazine; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
Extrapulmonary cytomegalovirus disease in transplant patients.
Topics: Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Heart Transplantation; Heart-Lung Transplantation; Humans; Immunotherapy; Kidney Transplantation; Liver Transplantation; Organ Transplantation; Phosphonoacetic Acid | 1991 |
Treatment of cytomegalovirus pneumonia in transplant patients.
Topics: Cytomegalovirus Infections; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Organ Transplantation; Phosphonoacetic Acid; Pneumonia, Viral | 1991 |
[Cytomegalovirus infections in transplant patients].
Topics: Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immune Tolerance; Incidence; Organ Transplantation; Phosphonoacetic Acid | 1991 |
[Antiviral agents for the systemic treatment of herpesvirus infections].
Topics: Acyclovir; Antiviral Agents; Foscarnet; Ganciclovir; Herpesviridae Infections; Humans; Phosphonoacetic Acid | 1991 |
[Treatment of herpesvirus infections].
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Herpes Simplex; Herpes Zoster; Herpesviridae Infections; Humans; Phosphonoacetic Acid | 1991 |
Advances in the prevention and treatment of cytomegalovirus infection in hospital patients.
Topics: Antibodies, Monoclonal; Antiviral Agents; Bronchoalveolar Lavage Fluid; Cross Infection; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Prognosis | 1991 |
Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis.
Topics: Acquired Immunodeficiency Syndrome; Anemia; Animals; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Humans; Phosphonoacetic Acid; Retinitis; Tissue Distribution | 1991 |
Zidovudine and other reverse transcriptase inhibitors in the management of human immunodeficiency virus-related disease.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Child; Didanosine; Female; Foscarnet; HIV Infections; Humans; Phosphonoacetic Acid; Pregnancy; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine | 1991 |
Antiviral therapeutics in dentistry.
Topics: Acyclovir; Antiviral Agents; Dental Care; Drug Combinations; Drug Resistance, Microbial; Foscarnet; Herpesviridae Infections; Humans; Immunocompromised Host; Interferons; Nucleosides; Phosphonoacetic Acid; Viral Vaccines | 1991 |
Cutaneous herpes simplex virus infections.
Topics: Acyclovir; Administration, Oral; Antiviral Agents; Diagnosis, Differential; Drug Resistance, Microbial; Foscarnet; Herpes Simplex; Humans; Idoxuridine; Infusions, Intravenous; Phosphonoacetic Acid; Recurrence; Skin Diseases, Infectious; Trifluridine; Vidarabine | 1991 |
Approaches to the treatment of cytomegalovirus retinitis: ganciclovir and foscarnet.
Topics: Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Eye Infections, Viral; Foscarnet; Ganciclovir; HIV Infections; Humans; Opportunistic Infections; Phosphonoacetic Acid; Retinitis | 1991 |
Diagnosis and treatment of cytomegalovirus retinitis.
Topics: Antiviral Agents; Cytomegalovirus Infections; Diagnosis, Differential; Eye Infections, Viral; Foscarnet; Ganciclovir; HIV Infections; Humans; Opportunistic Infections; Phosphonoacetic Acid; Retinitis | 1991 |
Foscarnet sodium.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Herpes Simplex; Humans; Phosphonoacetic Acid; Retinitis | 1991 |
Prospects of therapy for infections with human T-lymphotropic virus type III.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Antimony; Antiviral Agents; Combined Modality Therapy; Deltaretrovirus; Foscarnet; Humans; Immunotherapy; Interferons; Lactams, Macrocyclic; Phosphonoacetic Acid; Receptors, Virus; Reverse Transcriptase Inhibitors; Ribavirin; RNA Processing, Post-Transcriptional; RNA, Viral; Suramin; Tungsten; Tungsten Compounds; Virus Replication | 1985 |
Chemotherapeutic approaches to the treatment of the acquired immune deficiency syndrome (AIDS).
Topics: Acquired Immunodeficiency Syndrome; Adsorption; Antibodies, Viral; Antigens, Viral; Aurintricarboxylic Acid; Deltaretrovirus; Deoxycytidine; Foscarnet; Genes, Viral; Glycoproteins; Humans; Interferons; Male; Phosphonoacetic Acid; Retroviridae Infections; Reverse Transcriptase Inhibitors; Ribavirin; RNA, Viral; Suramin; Thymidine; Transcription, Genetic; Viral Proteins; Virus Replication; Zalcitabine; Zidovudine | 1986 |
Therapy of human immunodeficiency virus infections.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Foscarnet; Humans; Immunotherapy; Interferons; Oligodeoxyribonucleotides; Phosphonoacetic Acid; Ribavirin; Suramin; Thymidine; Zidovudine | 1987 |
Treatment of cytomegalovirus infection.
Topics: Acyclovir; Clinical Trials as Topic; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Interferons; Nucleosides; Phosphonoacetic Acid | 1987 |
Promising new antiviral drugs.
Topics: Acyclovir; Animals; Antiviral Agents; Bromodeoxyuridine; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Herpes Simplex; Herpes Zoster; Humans; Interferons; Phosphonoacetic Acid; Ribavirin; Thymidine; Zidovudine | 1988 |
Cotton-wool spots and cytomegalovirus retinitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Cytomegalovirus Infections; Diabetic Retinopathy; Diagnosis, Differential; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Pneumonia, Pneumocystis; Prognosis; Retinal Diseases; Retinitis; Zidovudine | 1989 |
Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
Topics: Adolescent; Adult; Animals; Antiviral Agents; Child; Female; Foscarnet; Guinea Pigs; Humans; Male; Mice; Nucleotidyltransferases; Organophosphorus Compounds; Phosphodiesterase Inhibitors; Phosphonoacetic Acid; Rabbits; Virus Diseases; Viruses | 1989 |
Cytomegalovirus infection in the acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Addison Disease; Antiviral Agents; Colitis; Cytomegalovirus Infections; Encephalitis; Esophageal Diseases; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Pneumonia, Viral; Retinitis | 1989 |
Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date.
Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Forecasting; Foscarnet; Immunotherapy; Phosphonoacetic Acid; Rifabutin; Rifamycins; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine | 1987 |
Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Gastroenteritis; Humans; Opportunistic Infections; Phosphonoacetic Acid; Pneumonia, Viral; Retinitis | 1988 |
Progress in the development of antiviral therapy for HTLV-III-associated diseases.
Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; HIV; Humans; Phosphonoacetic Acid; Ribavirin; Rifabutin; Rifamycins; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine | 1987 |
Management of cytomegalovirus infection.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Phosphonoacetic Acid; Pneumonia, Viral | 1988 |
The diagnosis of cytomegalovirus retinitis.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Diagnosis, Differential; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Opportunistic Infections; Phosphonoacetic Acid; Retinitis; Vision Disorders | 1988 |
The treatment of HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Dideoxynucleosides; Drug Evaluation; Foscarnet; Humans; Opportunistic Infections; Phosphonoacetic Acid; Zalcitabine; Zidovudine | 1988 |
[Treatment of cytomegalovirus infections in immunosuppressed patients].
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunologic Deficiency Syndromes; Organophosphorus Compounds; Phosphonoacetic Acid | 1988 |
Antiviral drugs for AIDS. Current status and future prospects.
Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; Humans; Interferon Type I; Phosphonoacetic Acid; Ribavirin; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine | 1986 |
Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
Topics: Animals; Antiviral Agents; Cell-Free System; Cells, Cultured; Chemical Phenomena; Chemistry; DNA-Directed RNA Polymerases; Foscarnet; Herpesviridae Infections; Humans; Kinetics; Nucleic Acid Synthesis Inhibitors; Organophosphorus Compounds; Phosphonoacetic Acid; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Virus Replication | 1982 |
[Etiological therapeutics in viral diseases].
Topics: Acyclovir; Amantadine; Animals; Antibodies, Viral; Antiviral Agents; Chemical Phenomena; Chemistry; Foscarnet; Idoxuridine; Immunity, Cellular; Immunity, Innate; Immunotherapy; Interferons; Phosphonoacetic Acid; Vidarabine; Virus Diseases; Virus Replication | 1984 |
[Herpes simplex].
Topics: Adolescent; Adult; Amantadine; Antigens, Viral; Cell Transformation, Viral; Female; Foscarnet; Herpes Genitalis; Herpes Labialis; Herpes Simplex; Humans; Idoxuridine; Immunity, Cellular; Immunosuppression Therapy; Male; Middle Aged; Oncogenic Viruses; Phosphonoacetic Acid; Recurrence; Simplexvirus; United States; Uterine Cervical Neoplasms; Viral Vaccines | 1981 |
Treatment of experimental latent herpes simplex virus infections with acyclovir and other antiviral compounds.
Topics: Acyclovir; Animals; Antiviral Agents; Culture Techniques; Foscarnet; Ganglia; Guanine; Herpes Simplex; Mice; Neurons; Phosphonoacetic Acid; Simplexvirus; Time Factors | 1982 |
28 trial(s) available for phosphonoacetic acid and foscarnet
| Article | Year |
|---|---|
The treatment of cytomegalovirus in AIDS--more than meets the eye.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Drug Tolerance; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis | 1992 |
Design of a randomized controlled trial of foscarnet in patients with cytomegalovirus retinitis associated with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Humans; Male; Phosphonoacetic Acid; Retinitis | 1992 |
Studies of ocular complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 1. Rationale, design, and methods. AIDS Clinical Trials Group (ACTG).
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Infections; Drug Administration Schedule; Fluorescein Angiography; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Multicenter Studies as Topic; Opportunistic Infections; Phosphonoacetic Acid; Randomized Controlled Trials as Topic; Retinitis | 1992 |
Treatment of HIV-related cytomegalovirus disease of the gastrointestinal tract with foscarnet.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Female; Foscarnet; Gastrointestinal Diseases; Humans; Male; Phosphonoacetic Acid | 1992 |
Phase I-II trial of foscarnet for prevention of cytomegalovirus infection in autologous and allogeneic marrow transplant recipients.
Topics: Adolescent; Adult; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Drug Evaluation; Female; Foscarnet; Humans; Kidney; Male; Middle Aged; Phosphonoacetic Acid; Prospective Studies; Transplantation, Autologous; Transplantation, Homologous | 1992 |
Effect of foscarnet therapy on human immunodeficiency virus p24 antigen levels in AIDS patients with cytomegalovirus retinitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Drug Evaluation; Foscarnet; HIV Core Protein p24; Humans; Middle Aged; Phosphonoacetic Acid; Retinitis; Zidovudine | 1992 |
Foscarnet and Ganciclovir in the treatment of CMV retinitis in AIDS patients: a randomised comparison.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; HIV Seropositivity; Humans; Male; Phosphonoacetic Acid; Retinitis | 1992 |
Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; CD4-Positive T-Lymphocytes; Cytomegalovirus Infections; Drug Therapy, Combination; Drug Tolerance; Foscarnet; Ganciclovir; Humans; Leukocyte Count; Phosphonoacetic Acid; Random Allocation; Retinitis; Zidovudine | 1992 |
Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results of a controlled, randomized, regimen-comparative trial.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Herpes Simplex; Humans; Phosphonoacetic Acid | 1992 |
A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Drug Resistance, Microbial; Female; Foscarnet; Herpes Genitalis; Humans; Male; Phosphonoacetic Acid; Recurrence; Simplexvirus; Stomatitis, Herpetic; Vidarabine | 1991 |
AIDS file.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis | 1991 |
A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Follow-Up Studies; Foscarnet; Humans; Middle Aged; Opportunistic Infections; Phosphonoacetic Acid; Retinitis; Time Factors; Visual Acuity | 1991 |
Foscarnet versus ganciclovir in the management of cytomegalovirus disease in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid | 1991 |
Treatment of acquired immune deficiency syndrome (AIDS)-related pneumonitis with foscarnet: a double-blind placebo controlled study.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Double-Blind Method; Foscarnet; HIV Seropositivity; Humans; Infusions, Intravenous; Male; Phosphonoacetic Acid; Pneumonia, Pneumocystis; Randomized Controlled Trials as Topic; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
[Chemotherapy and immunoprophylaxis of HIV infection].
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Foscarnet; HIV; Humans; Phosphonoacetic Acid; Reverse Transcriptase Inhibitors; Ribavirin; Suramin; Thymidine; Viral Vaccines; Virus Replication; Zidovudine | 1986 |
Treatment of cytomegalovirus infection.
Topics: Acyclovir; Clinical Trials as Topic; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Interferons; Nucleosides; Phosphonoacetic Acid | 1987 |
Sensitivity of cytomegalovirus to intravenous foscarnet treatment.
Topics: Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Female; Foscarnet; Humans; Kidney Diseases; Kidney Transplantation; Leukemia; Male; Microbial Sensitivity Tests; Organophosphorus Compounds; Phosphonoacetic Acid | 1986 |
From the National Institutes of Health. Progress in AIDS research.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Infections; Drug Therapy, Combination; Foscarnet; Humans; Interferon Type I; Phosphonoacetic Acid; Recombinant Proteins; Research; Vaccines; Zidovudine | 1988 |
The treatment of HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Dideoxynucleosides; Drug Evaluation; Foscarnet; Humans; Opportunistic Infections; Phosphonoacetic Acid; Zalcitabine; Zidovudine | 1988 |
Topical treatment of recurrent genital herpes simplex virus infections with trisodium phosphonoformate (foscarnet): double blind, placebo controlled, multicentre study.
Topics: Administration, Topical; Clinical Trials as Topic; Double-Blind Method; Female; Foscarnet; Herpes Genitalis; Humans; Male; Organophosphorus Compounds; Phosphonoacetic Acid; Recurrence; Time Factors | 1986 |
Clinical course of recurrent genital herpes and treatment with foscarnet cream: results of a Canadian multicenter trial.
Topics: Administration, Topical; Adolescent; Adult; Antiviral Agents; Clinical Trials as Topic; Double-Blind Method; Female; Foscarnet; Herpes Genitalis; Humans; Male; Middle Aged; Organophosphorus Compounds; Phosphonoacetic Acid; Random Allocation; Recurrence | 1987 |
Foscarnet (phosphonoformate sodium) in the treatment of recurrent male genital herpes.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antiviral Agents; Clinical Trials as Topic; Double-Blind Method; Foscarnet; Herpes Genitalis; Humans; Male; Middle Aged; Organophosphorus Compounds; Phosphonoacetic Acid; Random Allocation | 1986 |
Phosphonoformate (foscarnet): a pilot study in AIDS and AIDS related complex.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Antigens, Viral; Clinical Trials as Topic; Foscarnet; HIV; HIV Antigens; Humans; Organophosphorus Compounds; Phosphonoacetic Acid; Pilot Projects | 1987 |
The effect of foscarnet (phosphonoformate) on human immunodeficiency virus isolation, T-cell subsets and lymphocyte function in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antibodies, Viral; Clinical Trials as Topic; Foscarnet; HIV; HIV Antibodies; Humans; Leukocyte Count; Male; Organophosphorus Compounds; Phosphonoacetic Acid; T-Lymphocytes | 1987 |
Efficacy and safety of foscarnet for recurrent orolabial herpes: a multicentre randomized double-blind study.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antiviral Agents; Clinical Trials as Topic; Double-Blind Method; Female; Foscarnet; Herpes Labialis; Humans; Male; Middle Aged; Organophosphorus Compounds; Phosphonoacetic Acid; Random Allocation; Recurrence | 1988 |
Antiviral chemotherapy and chemoprophylaxis.
Topics: Acyclovir; Adult; Aged; Amantadine; Antiviral Agents; Chickenpox; Clinical Trials as Topic; Cytomegalovirus; Encephalitis; Foscarnet; Guanosine Triphosphate; Herpes Simplex; Herpes Zoster; Herpesviridae Infections; Humans; Infant, Newborn; Infant, Newborn, Diseases; Influenza A virus; Influenza, Human; Phosphonoacetic Acid; Respiratory Tract Infections; Ribavirin; Rimantadine; Vidarabine; Virus Diseases | 1985 |
Cytomegalovirus colitis and oesophageal ulceration in the context of AIDS: clinical manifestations and preliminary report of treatment with Foscarnet (phosphonoformate).
Topics: Acquired Immunodeficiency Syndrome; Adult; Clinical Trials as Topic; Colitis; Cytomegalovirus Infections; Esophageal Diseases; Foscarnet; Homosexuality; Humans; Male; Middle Aged; Organophosphorus Compounds; Phosphonoacetic Acid; Ulcer | 1987 |
Topical treatment of recurrent genital herpes infections with foscarnet.
Topics: Administration, Topical; Adult; Clinical Trials as Topic; Double-Blind Method; Erythema; Female; Foscarnet; Herpes Genitalis; Humans; Male; Organophosphorus Compounds; Phosphonoacetic Acid; Recurrence; Sex Factors | 1985 |
339 other study(ies) available for phosphonoacetic acid and foscarnet
| Article | Year |
|---|---|
Synthesis and antiviral activity of phosphonoacetic and phosphonoformic acid esters of 5-bromo-2'-deoxyuridine and related pyrimidine nucleosides and acyclonucleosides.
Topics: Antiviral Agents; Bromodeoxyuridine; Foscarnet; Organophosphorus Compounds; Phosphonoacetic Acid | 1989 |
Phosphonoformate and phosphonoacetate derivatives of 5-substituted 2'-deoxyuridines: synthesis and antiviral activity.
Topics: Animals; Antiviral Agents; Bromodeoxyuridine; Cell Line; Chemical Phenomena; Chemistry; Deoxyuridine; Foscarnet; Herpes Simplex; Mice; Organophosphorus Compounds; Pharmaceutical Preparations; Phosphonoacetic Acid; Prodrugs; Rabbits; Simplexvirus; Thymidine; Vero Cells | 1988 |
Phosphonoformate inhibits reverse transcriptase.
Topics: Animals; Antiviral Agents; Avian Myeloblastosis Virus; Foscarnet; Haplorhini; Leukemia Virus, Bovine; Magnesium; Manganese; Organophosphorus Compounds; Papio; Phosphonoacetic Acid; Rauscher Virus; Retroviridae; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Sarcoma Virus, Woolly Monkey; Templates, Genetic; Visna-maedi virus | 1979 |
From the National Institutes of Health.
Topics: Acquired Immunodeficiency Syndrome; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Arthritis, Rheumatoid; Coronary Disease; Cytomegalovirus Infections; Death, Sudden, Cardiac; Exercise Test; Eye Infections, Viral; Foscarnet; Humans; National Institutes of Health (U.S.); Phosphonoacetic Acid; Radionuclide Imaging; Retinitis; United States | 1992 |
Foscarnet.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Humans; Phosphonoacetic Acid; Retinitis | 1992 |
Didanosine and foscarnet marketed for use by patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Didanosine; Foscarnet; Humans; Phosphonoacetic Acid; Retinitis; United States; United States Food and Drug Administration | 1992 |
Clinical implications of herpesvirus infections in patients with AIDS. Introduction.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Herpes Simplex; Herpes Zoster; Herpesviridae Infections; Humans; Phosphonoacetic Acid; Retinitis | 1992 |
Treatment of cytomegalovirus retinitis--1992.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Recurrence; Retinitis | 1992 |
A point mutation within a distinct conserved region of the herpes simplex virus DNA polymerase gene confers drug resistance.
Topics: Acyclovir; Amino Acid Sequence; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Genes, Viral; Molecular Sequence Data; Mutation; Phosphonoacetic Acid; Sequence Alignment; Simplexvirus; Tyrosine; Viral Structural Proteins | 1992 |
[Acyclovir-resistant herpes simplex virus infections in immunocompromised patients].
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Bone Transplantation; Drug Resistance, Microbial; Female; Foscarnet; Herpes Simplex; Humans; Male; Phosphonoacetic Acid; Retrospective Studies; Simplexvirus | 1992 |
Treatment of aggressive cytomegalovirus retinitis with ganciclovir in combination with foscarnet in a child infected with human immunodeficiency virus.
Topics: Antiviral Agents; Child, Preschool; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; HIV Infections; Humans; Phosphonoacetic Acid; Retinitis | 1992 |
Why was treatment of cytomegalovirus retinitis randomized?
Topics: Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Randomized Controlled Trials as Topic; Retinitis | 1992 |
Cytomegalovirus and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis; Retrospective Studies | 1992 |
[Regressive diffuse leukoencephalitis under foscarnet in an AIDS infected patient].
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Encephalitis; Foscarnet; Humans; Male; Middle Aged; Opportunistic Infections; Phosphonoacetic Acid | 1992 |
[Effectiveness of phosphonoformic acid in herpes infections].
Topics: Animals; Antiviral Agents; Foscarnet; Guinea Pigs; Herpesviridae; Herpesviridae Infections; Phosphonoacetic Acid; Rabbits | 1992 |
Treatment of CMV retinitis.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis; Zidovudine | 1992 |
Treatment of CMV retinitis.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Kidney; Phosphonoacetic Acid; Retinitis | 1992 |
Treatment of CMV retinitis.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis | 1992 |
Foscarnet induction therapy for cytomegalovirus retinitis in AIDS: comparison of twice-daily and three-times-daily regimens.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Drug Administration Schedule; Drug Tolerance; Female; Foscarnet; Humans; Male; Middle Aged; Phosphonoacetic Acid; Retinitis | 1992 |
Therapeutic algorithm for treatment of cytomegalovirus retinitis in persons with AIDS. A roundtable summary.
Topics: Acquired Immunodeficiency Syndrome; Adult; Algorithms; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Male; Phosphonoacetic Acid; Retinitis | 1992 |
CMV polyradiculopathy in AIDS--suggestions for new strategies in treatment.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cytomegalovirus Infections; Foscarnet; Humans; Male; Nervous System Diseases; Phosphonoacetic Acid; Zidovudine | 1992 |
Clinical effects and in vitro studies of trifluorothymidine combined with interferon-alpha for treatment of drug-resistant and -sensitive herpes simplex virus infections.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Combined Modality Therapy; Cytopathogenic Effect, Viral; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Female; Foscarnet; Herpes Simplex; Humans; Interferon Type I; Male; Phosphonoacetic Acid; Recombinant Proteins; Recurrence; Simplexvirus; Trifluridine; Virus Replication | 1992 |
Renal Na(+)-phosphate cotransport in X-linked Hyp mice responds appropriately to Na+ gradient, membrane potential, and pH.
Topics: Animals; Arsenates; Biological Transport; Foscarnet; Genetic Linkage; Hydrogen-Ion Concentration; Hypophosphatemia, Familial; Kidney; Membrane Potentials; Mice; Mice, Mutant Strains; Microvilli; Phosphates; Phosphonoacetic Acid; Sodium; X Chromosome | 1992 |
Herpes simplex virus infection during foscarnet therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Herpes Simplex; Humans; Male; Phosphonoacetic Acid; Retinitis | 1992 |
Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients.
Topics: Adolescent; Adult; Antiviral Agents; Bone Marrow Transplantation; Calcium; Child; Child, Preschool; Cytomegalovirus Infections; Female; Foscarnet; Hemoglobins; Humans; Infant; Infusions, Intravenous; Kidney; Liver; Male; Middle Aged; Phosphates; Phosphonoacetic Acid | 1992 |
Experimental in vivo generation of intertypic recombinant strains of HSV in the mouse.
Topics: Animals; Female; Foscarnet; Ganglia, Sympathetic; Herpes Simplex; Mice; Mice, Inbred Strains; Phosphonoacetic Acid; Recombination, Genetic; Simplexvirus; Skin; Species Specificity; Vero Cells; Virus Replication | 1992 |
Heterogeneity of a herpes simplex virus clinical isolate exhibiting resistance to acyclovir and foscarnet.
Topics: Acyclovir; Animals; Drug Resistance, Microbial; Foscarnet; Genetic Variation; Herpes Simplex; Humans; Phosphonoacetic Acid; Simplexvirus | 1992 |
[Myelo-meningoradiculitis secondary to cytomegalovirus infection in a non immunocompromised patient. Treatment with foscarnet].
Topics: Adolescent; Antiviral Agents; Bone Marrow Diseases; Cytomegalovirus Infections; Foscarnet; Humans; Male; Meningitis, Viral; Phosphonoacetic Acid; Radiculopathy | 1992 |
A ganciclovir-resistant clinical isolate of human cytomegalovirus exhibiting cross-resistance to other DNA polymerase inhibitors.
Topics: Antiviral Agents; Chromatography, High Pressure Liquid; Cytomegalovirus; Drug Resistance, Microbial; Enzyme-Linked Immunosorbent Assay; Foscarnet; Ganciclovir; Humans; Nucleic Acid Synthesis Inhibitors; Phosphonoacetic Acid; Viral Plaque Assay | 1992 |
Treatment of CMV retinitis.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis; Zidovudine | 1992 |
Foscarnet for CMV retinitis.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Kidney Function Tests; Phosphonoacetic Acid; Retinitis | 1992 |
Ganciclovir/foscarnet for cytomegalovirus meningoencephalitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Male; Meningoencephalitis; Phosphonoacetic Acid | 1992 |
Biochemical mechanisms of C-P bond formation of bialaphos: use of gene manipulation for the analysis of the C-P bond formation step.
Topics: DNA; Foscarnet; Genetic Engineering; Mutation; Organophosphorus Compounds; Phosphoenolpyruvate; Phosphonoacetic Acid; Plasmids; Streptomyces | 1990 |
The binding of a novel bisheteroarylpiperazine mediates inhibition of human immunodeficiency virus type 1 reverse transcriptase.
Topics: Benzodiazepines; Binding, Competitive; Dideoxynucleosides; Foscarnet; HIV-1; Imidazoles; Indoles; Nevirapine; Phosphonoacetic Acid; Piperazines; Pyridines; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase | 1992 |
In vitro selection and molecular characterization of human immunodeficiency virus-1 resistant to non-nucleoside inhibitors of reverse transcriptase.
Topics: Antiviral Agents; Base Sequence; Benzodiazepines; CD4-Positive T-Lymphocytes; Cloning, Molecular; Drug Resistance, Microbial; Foscarnet; Gene Expression; HeLa Cells; HIV-1; Humans; Imidazoles; Molecular Sequence Data; Nevirapine; Phosphonoacetic Acid; Polymerase Chain Reaction; Pyridines; Recombinant Proteins; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Zidovudine | 1992 |
HIV-1 reverse transcriptase inhibition by a dipyridodiazepinone derivative: BI-RG-587.
Topics: Antiviral Agents; Foscarnet; HIV-1; Kinetics; Nevirapine; Phosphonoacetic Acid; Pyridines; Reverse Transcriptase Inhibitors; Templates, Genetic; Zidovudine | 1992 |
De novo reverse transcription is a crucial event in cell-to-cell transmission of human immunodeficiency virus.
Topics: Antiviral Agents; DNA, Viral; Foscarnet; HIV Reverse Transcriptase; HIV-1; Humans; Middle Aged; Phosphonoacetic Acid; RNA-Directed DNA Polymerase; Virus Replication; Zidovudine | 1992 |
Dual action of phosphonoformic acid on Na(+)-phosphate cotransport in opossum kidney cells.
Topics: Animals; Biological Transport; Carboxylic Acids; Carrier Proteins; Cell Line; Foscarnet; Kidney; Kinetics; Opossums; Organophosphonates; Phosphates; Phosphonoacetic Acid; Proteins; RNA; Sodium-Phosphate Cotransporter Proteins; Symporters; Time Factors; Up-Regulation | 1992 |
[Development of resistance of herpes simplex virus to antivirus drugs in vitro].
Topics: Acyclovir; Ancitabine; Animals; Antiviral Agents; Drug Combinations; Drug Resistance, Microbial; Foscarnet; Phosphonoacetic Acid; Simplexvirus; Vero Cells | 1992 |
Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus.
Topics: CD4 Antigens; Cell Line; DNA-Directed RNA Polymerases; Enzyme-Linked Immunosorbent Assay; Foscarnet; HIV Core Protein p24; HIV Envelope Protein gp120; HIV-1; Humans; In Vitro Techniques; Microscopy, Electron; Neutralization Tests; Phosphonoacetic Acid; Solubility; Temperature; Ultracentrifugation; Viral Proteins; Virion | 1992 |
Foscarnet and pancytopenia.
Topics: Adult; Antiviral Agents; Foscarnet; Humans; Pancytopenia; Phosphonoacetic Acid | 1992 |
Pharmacokinetics of potential anti-AIDS agents thiofoscarnet and foscarnet in the cat.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Animals; Antiviral Agents; Biological Availability; Cats; Female; Foscarnet; Infusions, Intravenous; Phosphonoacetic Acid | 1992 |
[Type 1 herpesvirus cutaneo-mucous infection resistant to aciclovir in a HIV infected patient. Clinical and virological study].
Topics: Acyclovir; Adult; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Herpes Simplex; HIV Infections; Humans; Male; Opportunistic Infections; Phosphonoacetic Acid; Skin Diseases | 1992 |
Phosphate transport in brush border membranes from uremic rats. Response to phosphonoformic acid.
Topics: Animals; Foscarnet; In Vitro Techniques; Ion Transport; Jejunum; Kidney; Kinetics; Microvilli; Phosphates; Phosphonoacetic Acid; Rats; Rats, Sprague-Dawley; Uremia | 1992 |
Expression of rat renal sodium/phosphate cotransporter in Xenopus laevis oocytes.
Topics: Animals; Biological Transport; Carrier Proteins; Cloning, Molecular; Foscarnet; Kidney; Kinetics; Oocytes; Phosphonoacetic Acid; Rats; RNA, Messenger; Sodium-Phosphate Cotransporter Proteins; Symporters; Xenopus laevis | 1992 |
[Prevention of genital ulcerations during treatment with foscarnet].
Topics: Antiviral Agents; Female; Foscarnet; Genital Diseases, Female; Genital Diseases, Male; Humans; Male; Phosphonoacetic Acid; Ulcer | 1992 |
Mechanisms of heterogeneity of Na(+)-Pi cotransport in superficial and juxtamedullary renal cortex.
Topics: Animals; Biological Transport; Carrier Proteins; Cell Membrane; Electrochemistry; Foscarnet; Kidney Cortex; Kinetics; Microvilli; Phosphates; Phosphonoacetic Acid; Potassium; Rats; Rats, Inbred Strains; Sodium; Sodium-Phosphate Cotransporter Proteins; Symporters; Temperature | 1992 |
Early appearance of simian immunodeficiency virus (SIV) antigen and antibodies as variables in evaluating antiviral drugs in macaques.
Topics: Amino Acid Sequence; Animals; Antibodies, Viral; Antigens, Viral; Antiviral Agents; Drug Evaluation; env Gene Products, Human Immunodeficiency Virus; Enzyme-Linked Immunosorbent Assay; Foscarnet; Gene Products, env; HIV Antigens; Immunoglobulin G; Immunoglobulin M; Macaca fascicularis; Molecular Sequence Data; Monitoring, Immunologic; Peptide Fragments; Phosphonoacetic Acid; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Virus Replication | 1992 |
[Resistance of viruses to antiviral agents].
Topics: Acyclovir; Antiviral Agents; Drug Resistance; Foscarnet; Humans; Immunocompromised Host; Phosphonoacetic Acid; Rimantadine; Virus Diseases; Zidovudine | 1992 |
Treatment of CMV retinitis.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Drug Synergism; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Zidovudine | 1992 |
Hypocalcemia induced by foscarnet (Foscavir) infusion in dogs.
Topics: Animals; Blood Cell Count; Calcitriol; Dogs; Foscarnet; Homeostasis; Hypocalcemia; Infusions, Intravenous; Male; Parathyroid Hormone; Phosphonoacetic Acid | 1992 |
Vulval ulceration associated with foscarnet.
Topics: Adult; Antiviral Agents; Female; Foscarnet; Humans; Phosphonoacetic Acid; Skin Ulcer; Vulvar Diseases | 1992 |
Additional data on visual compatibility of foscarnet sodium with morphine sulfate.
Topics: Antiviral Agents; Drug Incompatibility; Drug Stability; Foscarnet; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Morphine; Phosphonoacetic Acid | 1992 |
Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Male; Ophthalmoscopy; Phosphonoacetic Acid; Retinitis | 1991 |
Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Cohort Studies; Drug Resistance, Microbial; Foscarnet; Herpes Zoster; Herpesvirus 3, Human; Humans; Middle Aged; Phosphonoacetic Acid; Skin Diseases, Infectious | 1991 |
Foscarnet in the treatment of cytomegalovirus infection of the esophagus and colon in patients with the acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Colitis; Cytomegalovirus Infections; Esophageal Diseases; Female; Foscarnet; Humans; Male; Middle Aged; Phosphonoacetic Acid; Remission Induction; Retrospective Studies; Ulcer | 1991 |
Acyclovir-resistant varicella zoster responsive to foscarnet.
Topics: Acyclovir; Adult; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Herpes Zoster; Herpesvirus 3, Human; HIV Infections; Humans; Male; Phosphonoacetic Acid; Skin Diseases, Infectious | 1991 |
Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNA.
Topics: Antigens, Viral; Burkitt Lymphoma; Cell Line; Child; Child, Preschool; DNA Probes; DNA, Viral; Epstein-Barr Virus Nuclear Antigens; Female; Foscarnet; Gene Expression Regulation, Viral; Herpesvirus 4, Human; Humans; Male; Methylation; Phosphonoacetic Acid; Tumor Cells, Cultured | 1991 |
Foscarnet therapy of ganciclovir-resistant cytomegalovirus in marrow transplantation.
Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Female; Foscarnet; Ganciclovir; Humans; Microbial Sensitivity Tests; Phosphonoacetic Acid; Pneumonia, Viral | 1991 |
Isolation of foscarnet-resistant human cytomegalovirus patterns of resistance and sensitivity to other antiviral drugs.
Topics: Antiviral Agents; Cells, Cultured; Cytomegalovirus; Drug Resistance, Microbial; Fibroblasts; Foscarnet; Humans; Mutation; Neutralization Tests; Nucleic Acid Hybridization; Phosphonoacetic Acid; Serial Passage | 1991 |
Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring.
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adult; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Humans; Male; Phosphonoacetic Acid; Renal Dialysis; Retinitis | 1991 |
Drugs recently released in Belgium. Foscarnet - pinacidil.
Topics: Antiviral Agents; Foscarnet; Guanidines; Humans; Phosphonoacetic Acid; Pinacidil; Vasodilator Agents | 1991 |
National Eye Institute issues clinical alert about CMV retinitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Male; Phosphonoacetic Acid; Retinitis | 1991 |
Foscarnet approved for cytomegalovirus retinitis.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Humans; Phosphonoacetic Acid; Retinitis | 1991 |
Cytomegalovirus infection in heart-lung transplant recipients: risk factors, clinical associations, and response to treatment.
Topics: Adolescent; Adult; Antibodies, Viral; Bacterial Infections; Child; Cytomegalovirus; Cytomegalovirus Infections; Female; Follow-Up Studies; Foscarnet; Ganciclovir; Heart-Lung Transplantation; Humans; Immunization, Passive; Immunosuppression Therapy; Male; Middle Aged; Phosphonoacetic Acid; Pneumonia, Viral; Retrospective Studies; Risk Factors; Tissue Donors; Transfusion Reaction; Virus Diseases | 1991 |
From the Food and Drug Administration.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Food Labeling; Foscarnet; Humans; Hydrocortisone; Nonprescription Drugs; Phosphonoacetic Acid; Retinitis; United States; United States Food and Drug Administration | 1991 |
Cytomegalovirus infection in AIDS. Patterns of disease, response to therapy and trends in survival.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Colitis; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Humans; London; Male; Neutropenia; Opportunistic Infections; Phosphonoacetic Acid; Prevalence; Recurrence; Retinitis; Retrospective Studies; Survival Rate; Thrombocytopenia; Zidovudine | 1991 |
[Prevention of genital erosions during treatments with foscarnet of cytomegalovirus infections in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Humans; Male; Opportunistic Infections; Penile Diseases; Phosphonoacetic Acid | 1991 |
Survival of patients with AIDS and cytomegalovirus disease treated with ganciclovir or foscarnet.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Opportunistic Infections; Phosphonoacetic Acid; Retinitis; Survival Rate | 1991 |
Modified tetrazolium-based colorimetric method for determining the activities of anti-HIV compounds.
Topics: Antiviral Agents; Cell Line; Colorimetry; Didanosine; Foscarnet; HIV-1; Humans; Phosphonoacetic Acid; Tetrazolium Salts; Thymidine; Zalcitabine; Zidovudine | 1991 |
Early virus isolation, early structural antigen detection and DNA amplification by the polymerase chain reaction in polymorphonuclear leukocytes from AIDS patients with human cytomegalovirus viraemia.
Topics: Acquired Immunodeficiency Syndrome; Antigens, Viral; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Foscarnet; Ganciclovir; Humans; Neutrophils; Phosphonoacetic Acid; Polymerase Chain Reaction; Retinitis; Viral Proteins | 1991 |
[Therapeutic alternative or 2d choice drug. Trisodium phosphonoformate in cytomegalovirus retinitis].
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Chorioretinitis; Cytomegalovirus Infections; Drug Therapy, Combination; Fluorescein Angiography; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Opportunistic Infections; Phosphonoacetic Acid | 1991 |
Sensitive, reproducible and convenient fluorometric assay for the in vitro evaluation of anti-cytomegalovirus agents.
Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Esterases; Flow Cytometry; Fluoresceins; Fluorometry; Foscarnet; Ganciclovir; Humans; Microbial Sensitivity Tests; Organophosphonates; Organophosphorus Compounds; Phosphonoacetic Acid; Polyethylene Glycols; Suramin | 1991 |
Thromboembolic disease in AIDS is associated with cytomegalovirus disease.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Phosphonoacetic Acid; Thromboembolism | 1991 |
Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient.
Topics: Adult; Antiviral Agents; Bone Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance; Female; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid | 1991 |
Simultaneous treatment of cytomegalovirus retinitis with ganciclovir and foscarnet.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Male; Phosphonoacetic Acid; Retinitis | 1991 |
Treatment of cytomegalovirus retinitis with ganciclovir and foscarnet.
Topics: Adult; Cytomegalovirus Infections; Drug Combinations; Foscarnet; Ganciclovir; HIV Seropositivity; Humans; Male; Middle Aged; Phosphonoacetic Acid; Recurrence; Retinitis | 1991 |
Seeing the way forward for treatment of CMV retinitis.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis | 1991 |
Mutational analysis of two conserved sequence motifs in HIV-1 reverse transcriptase.
Topics: Amino Acid Sequence; Dideoxynucleotides; DNA Mutational Analysis; Foscarnet; HIV-1; In Vitro Techniques; Kinetics; Molecular Sequence Data; Phosphonoacetic Acid; Recombinant Proteins; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Structure-Activity Relationship; Thymine Nucleotides; Zidovudine | 1991 |
The characterization of EIAV reverse transcriptase and its inhibition by 5'-triphosphates of 2'-deoxyuridine analogs, PFA and PAA.
Topics: Antiviral Agents; Dideoxynucleotides; Foscarnet; HIV; Infectious Anemia Virus, Equine; Phosphonoacetic Acid; RNA-Directed DNA Polymerase; Thymine Nucleotides; Zidovudine | 1990 |
Synergistic combinations and peptides in the inhibition of human immunodeficiency virus.
Topics: Alpha-Globulins; Amino Acid Sequence; Antiviral Agents; Cell Line; Dideoxynucleosides; Drug Synergism; Foscarnet; HIV; Humans; Molecular Sequence Data; Oligopeptides; Phosphonoacetic Acid; Proteins; Reverse Transcriptase Inhibitors; Serine Proteinase Inhibitors; Virus Replication; Zidovudine | 1991 |
CMV retinitis and the use of FK 506.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Humans; Immunosuppression Therapy; Phosphonoacetic Acid; Retinitis; Retrospective Studies; Tacrolimus; Transplantation Immunology | 1991 |
[Cytomegalovirus ileocolitis in patients with HIV infection is a treatable cause of severe abdominal problems].
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cecum; Crohn Disease; Cytomegalovirus Infections; Foscarnet; Humans; Ileum; Male; Middle Aged; Opportunistic Infections; Palliative Care; Phosphonoacetic Acid | 1991 |
Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine.
Topics: Antiviral Agents; Cell Line; Cell Survival; Cell-Free System; Dideoxynucleosides; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Foscarnet; HIV-1; Humans; Phosphonoacetic Acid; Reverse Transcriptase Inhibitors; Virus Replication; Zidovudine | 1991 |
Prophylactic and therapeutic effects of phosphonoformate against feline leukemia virus in vitro.
Topics: Animals; Antigens, Viral; Antiviral Agents; Cats; Cell Division; Cell Line, Transformed; Foscarnet; Leukemia Virus, Feline; Lymphoma; Phosphonoacetic Acid; Reverse Transcriptase Inhibitors; Tumor Cells, Cultured | 1991 |
Photoaffinity labeling of brush-border membrane proteins which bind phosphonoformic acid.
Topics: Affinity Labels; Animals; Azides; Biological Transport; Carrier Proteins; Foscarnet; Kidney Cortex; Kinetics; Membrane Proteins; Microvilli; Molecular Weight; NAD; Phosphates; Phosphonoacetic Acid; Photochemistry; Sodium; Sodium-Phosphate Cotransporter Proteins; Symporters | 1991 |
Interference of antiviral substances with replication of hepatitis delta virus RNA in primary woodchuck hepatocytes.
Topics: Acyclovir; Animals; Antiviral Agents; Cells, Cultured; Foscarnet; Hepatitis Delta Virus; Liver; Marmota; Phosphonoacetic Acid; Ribavirin; RNA, Viral; Virus Replication | 1991 |
Successful treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection explained by inhibitory effect on the immune response?
Topics: Antiviral Agents; B-Lymphocytes; Cell Line; Cells, Cultured; DNA; Foscarnet; Hepatitis B; Hepatitis D; Humans; Immunoglobulin G; Immunoglobulin M; Interferon-gamma; Interleukin-2; Lymphocyte Activation; Monocytes; Phosphonoacetic Acid; T-Lymphocytes; Tumor Necrosis Factor-alpha | 1991 |
Foscarnet-induced hypocalcemia and effects of foscarnet on calcium metabolism.
Topics: Antiviral Agents; Calcium; Dose-Response Relationship, Drug; Foscarnet; Herpes Simplex; Humans; Hypocalcemia; Opportunistic Infections; Phosphates; Phosphonoacetic Acid | 1991 |
Covalent and non-covalent inhibitors of the phosphate transporter of sarcoplasmic reticulum.
Topics: Acetic Anhydrides; Adenosine Triphosphatases; Animals; Binding Sites; Biological Transport; Calcium; Carrier Proteins; Female; Foscarnet; Maleates; Membrane Proteins; Muscles; Phenylglyoxal; Phosphate-Binding Proteins; Phosphates; Phosphonoacetic Acid; Rabbits; Sarcoplasmic Reticulum; Succinates; Succinic Acid | 1991 |
[Chronic erosive, therapy-resistant perianal herpes (type II) with herpes proctitis in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Foscarnet; Herpes Genitalis; Humans; Infusions, Intravenous; Male; Opportunistic Infections; Phosphonoacetic Acid; Proctitis | 1991 |
In vivo additive antiretroviral effect of combined zidovudine and foscarnet therapy for human immunodeficiency virus infection (ACTG Protocol 053).
Topics: Administration, Oral; Antiviral Agents; Drug Therapy, Combination; Follow-Up Studies; Foscarnet; Gene Products, gag; HIV Antigens; HIV Core Protein p24; HIV Infections; Humans; Infusions, Intravenous; Phosphonoacetic Acid; Viral Core Proteins; Zidovudine | 1991 |
Herpes simplex virus type-2 ulcers resistant to acyclovir in an AIDS patient--successful treatment with foscarnet.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Anus Diseases; Drug Resistance, Microbial; Foscarnet; Herpes Simplex; Humans; Male; Phosphonoacetic Acid | 1991 |
Quantitation of the Na(+)-Pi cotransporter in renal cortical brush border membranes. [14C]phosphonoformic acid as a useful probe to determine the density and its change in response to parathyroid hormone.
Topics: Animals; Blood Pressure; Carrier Proteins; Foscarnet; Glomerular Filtration Rate; Kidney Cortex; Male; Microvilli; Organophosphorus Compounds; Osmolar Concentration; Parathyroid Hormone; Phosphonoacetic Acid; Rats; Rats, Inbred Strains; Sodium-Phosphate Cotransporter Proteins; Symporters; Temperature | 1991 |
Age-related differences in phosphonoformate-induced bone toxicity in cats.
Topics: Age Factors; Alkaline Phosphatase; Animals; Bone and Bones; Bone Resorption; Calcification, Physiologic; Calcium; Cats; Foscarnet; Osteomalacia; Phosphonoacetic Acid; Phosphorus; Rickets | 1991 |
Mineralization disturbances of the developing rat molar induced by mono- and bisphosphonates.
Topics: Alveolar Process; Animals; Calcification, Physiologic; Clodronic Acid; Dental Enamel; Dentin; Diphosphonates; Etidronic Acid; Female; Foscarnet; Male; Microradiography; Molar; Odontogenesis; Organophosphonates; Phosphonoacetic Acid; Rats; Rats, Inbred Strains; Tooth Calcification; Tooth Germ | 1991 |
Renal brush-border membrane Na(+)-sulfate cotransport: stimulation by thyroid hormone.
Topics: Animals; Biological Transport; Carrier Proteins; Crosses, Genetic; Female; Foscarnet; Glucose; Kidney Cortex; Kinetics; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Microvilli; Phosphates; Phosphonoacetic Acid; Sodium; Sulfates; Triiodothyronine | 1991 |
Acyclovir resistance/susceptibility in herpes simplex virus type 2 sequential isolates from an AIDS patient.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Drug Resistance, Microbial; Follow-Up Studies; Foscarnet; Herpes Simplex; HIV-2; Humans; Male; Microbial Sensitivity Tests; Phosphonoacetic Acid | 1991 |
Reconstitution of the renal brush-border membrane sodium/phosphate co-transporter.
Topics: Animals; Carrier Proteins; Cattle; Electrophoresis, Polyacrylamide Gel; Foscarnet; Kidney; Membrane Proteins; Microvilli; Monensin; Phosphonoacetic Acid; Sodium-Phosphate Cotransporter Proteins; Substrate Specificity; Symporters | 1991 |
Characterization of a Pi transport system in cartilage matrix vesicles. Potential role in the calcification process.
Topics: Alkaline Phosphatase; Animals; Arsenates; Calcification, Physiologic; Calcium; Cations; Chickens; Extracellular Matrix; Foscarnet; Growth Plate; Hydrogen-Ion Concentration; Kinetics; Levamisole; Osmolar Concentration; Phosphates; Phosphonoacetic Acid; Sodium | 1991 |
Foscarnet and extended survival in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Foscarnet; Phosphonoacetic Acid; Survival Rate | 1991 |
Generalised cutaneous rash associated with foscarnet usage in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Erythema; Foscarnet; Humans; Male; Phosphonoacetic Acid | 1991 |
Foscarnet effective in acyclovir-resistant herpes.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Herpes Simplex; Humans; Injections, Intravenous; Phosphonoacetic Acid; Recurrence; Vidarabine | 1991 |
Sodium-phosphate cotransport and vascular reactivity.
Topics: Angiotensin II; Animals; Aorta; Carrier Proteins; Foscarnet; Mesenteric Arteries; Mesenteric Veins; Muscle Contraction; Muscle, Smooth, Vascular; Phosphates; Phosphonoacetic Acid; Rabbits; Sodium-Phosphate Cotransporter Proteins; Symporters | 1991 |
Experimental therapy of human glioma by means of a genetically engineered virus mutant.
Topics: Animals; Antiviral Agents; Brain Neoplasms; Cells, Cultured; Dose-Response Relationship, Drug; Foscarnet; Glioma; Mice; Mice, Nude; Mutagenesis; Phosphonoacetic Acid; Simplexvirus; Thymidine Kinase; Vidarabine; Viral Vaccines | 1991 |
Increased efficacy of ganciclovir and foscarnet inhibition of cytomegalovirus replication in vitro by encapsulation in liposomes.
Topics: Antiviral Agents; Cells, Cultured; Cytomegalovirus; Drug Carriers; Fibroblasts; Foscarnet; Ganciclovir; Humans; Liposomes; Phosphonoacetic Acid; Viral Plaque Assay; Virus Replication | 1990 |
Foscarnet and penile ulceration.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Herpes Simplex; Male; Penile Diseases; Phosphonoacetic Acid; Time Factors; Ulcer | 1990 |
Genital and oral erosions induced by foscarnet.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Foscarnet; Genital Diseases, Male; Humans; Male; Mouth Diseases; Phosphonoacetic Acid; Ulcer | 1990 |
Penile ulcerations with foscarnet.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Homosexuality; Humans; Male; Penile Diseases; Phosphonoacetic Acid; Skin Ulcer | 1990 |
Foscarnet and crystals in glomerular capillary lumens.
Topics: Antiviral Agents; Capillaries; Crystallization; Foscarnet; Humans; Kidney Glomerulus; Phosphonoacetic Acid | 1990 |
HIV-associated haemophagocytic syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Antiviral Agents; Drug Therapy, Combination; Foscarnet; Histiocytosis, Non-Langerhans-Cell; Humans; Male; Phosphonoacetic Acid; Zidovudine | 1990 |
Visual compatibility of foscarnet with other injectable drugs.
Topics: Chemistry, Pharmaceutical; Drug Incompatibility; Foscarnet; Phosphonoacetic Acid | 1990 |
Forscarnet-induced tubulointerstitial nephritis in renal transplant patients.
Topics: Antiviral Agents; Foscarnet; Humans; Kidney Transplantation; Nephritis, Interstitial; Phosphonoacetic Acid | 1990 |
Determination of phosphonoformic acid in human plasma and urine by high-performance liquid chromatography with electrochemical detection.
Topics: Cathartics; Chromatography, High Pressure Liquid; Electrochemistry; Foscarnet; Humans; Phosphonoacetic Acid | 1990 |
Heterogeneity of Pi transport by BBM from superficial and juxtamedullary cortex of rat.
Topics: Animals; Biological Transport; Carrier Proteins; Foscarnet; Kidney Cortex; Kidney Medulla; Kinetics; Lipid Metabolism; Male; Membrane Fluidity; Microvilli; Phosphates; Phosphonoacetic Acid; Rats; Rats, Inbred Strains; Sodium-Phosphate Cotransporter Proteins; Symporters; Temperature | 1990 |
Age-related differences in pharmacokinetics of phosphonoformate in cats.
Topics: Administration, Oral; Aging; Animals; Biological Availability; Cats; Foscarnet; Half-Life; Injections, Intravenous; Phosphonoacetic Acid; Protein Binding | 1990 |
Postexposure treatment of experimental DHBV infection: a new therapeutic strategy.
Topics: Acyclovir; Animals; Antiviral Agents; DNA, Viral; Ducks; Female; Foscarnet; Hepatitis B Virus, Duck; Hepatitis, Viral, Animal; Male; Phosphonoacetic Acid | 1990 |
Sulfate inhibits [14C]phosphonoformic acid binding to renal brush-border membranes.
Topics: Animals; Carbon Radioisotopes; Foscarnet; Hydrogen-Ion Concentration; Kidney; Kinetics; Male; Mice; Mice, Inbred C57BL; Microvilli; Osmolar Concentration; Phosphates; Phosphonoacetic Acid; Sodium; Sulfates | 1990 |
Normal molecular size of the Na(+)-phosphate cotransporter and normal Na(+)-dependent binding of phosphonoformic acid in renal brush border membranes of X-linked Hyp mice.
Topics: Animals; Carrier Proteins; Foscarnet; Hypophosphatemia, Familial; Kidney; Male; Mice; Mice, Mutant Strains; Microvilli; Phosphates; Phosphonoacetic Acid; Sodium; Sodium-Phosphate Cotransporter Proteins; Symporters | 1990 |
Lipid conjugates of antiretroviral agents. II. Disodium palmityl phosphonoformate: anti-HIV activity, physical properties, and interaction with plasma proteins.
Topics: Antiviral Agents; Cell Fusion; Cell Line; Chemical Phenomena; Chemistry, Physical; Foscarnet; HIV; In Vitro Techniques; Lipoproteins; Palmitates; Palmitic Acids; Phosphonoacetic Acid; Retroviridae Proteins; Serum Albumin, Bovine | 1990 |
Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Chromatography, Thin Layer; Drug Combinations; Drug Incompatibility; Foscarnet; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Phosphonoacetic Acid | 1990 |
Different molecular sizes for Na(+)-dependent phosphonoformic acid binding and phosphate transport in renal brush border membrane vesicles.
Topics: Animals; Biological Transport; Foscarnet; Kidney; Male; Microvilli; Phosphates; Phosphonoacetic Acid; Rats; Rats, Inbred Strains; Sodium | 1990 |
Generalised cutaneous rash associated with foscarnet usage in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Drug Eruptions; Foscarnet; Ganciclovir; HIV Seropositivity; Humans; Male; Phosphonoacetic Acid | 1990 |
Inhibition of African swine fever virus in cultured swine monocytes by phosphonoacetic acid (PAA) and by phosphonoformic acid (PFA).
Topics: African Swine Fever Virus; Animals; Antibodies, Monoclonal; Antigens, Viral; Antiviral Agents; Cell Division; Cell Fractionation; Cells, Cultured; Cytopathogenic Effect, Viral; DNA; Electrophoresis, Polyacrylamide Gel; Foscarnet; Macrophage Colony-Stimulating Factor; Monocytes; Phosphonoacetic Acid; Precipitin Tests; Radioimmunoassay; Swine; Virus Cultivation; Virus Replication | 1990 |
[Triapten ointment in the treatment of herpes genitalis in the female].
Topics: Antiviral Agents; Female; Foscarnet; Herpes Genitalis; Humans; Ointments; Phosphonoacetic Acid; Uterine Cervicitis; Vaginitis; Vulvitis | 1990 |
[Aciclovir-resistant herpes simplex virus infection in an immuno-depressed patient. Favourable effect of foscarnet].
Topics: Acyclovir; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Herpes Simplex; HIV Seropositivity; Homosexuality; Humans; Male; Phosphonoacetic Acid | 1990 |
Phosphonato complexes of platinum(II): kinetics of formation and phosphorus-31 NMR characterization studies.
Topics: Cisplatin; Diphosphonates; Foscarnet; Kinetics; Magnetic Resonance Spectroscopy; Organophosphonates; Phosphonoacetic Acid; Phosphorus Radioisotopes; X-Ray Diffraction | 1990 |
Heterotypic and homotypic re-inoculation of mice already latently infected with herpes simplex virus type 1.
Topics: Animals; Antiviral Agents; Drug Resistance, Microbial; Female; Foscarnet; Herpes Simplex; Mice; Mice, Inbred Strains; Mutation; Phosphonoacetic Acid; Simplexvirus; Time Factors | 1990 |
[Treatment of Cytomegalovirus infection].
Topics: Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immune Tolerance; Phosphonoacetic Acid | 1990 |
Foscarnet therapy of cytomegalovirus retinitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Humans; Phosphonoacetic Acid; Retinitis | 1990 |
Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro.
Topics: Cytomegalovirus; DNA, Viral; Drug Synergism; Foscarnet; Ganciclovir; Phosphonoacetic Acid; Virus Replication | 1990 |
Early selective effects of gentamicin on renal brush-border membrane Na-Pi cotransport and Na-H exchange.
Topics: Animals; Biological Transport; Carrier Proteins; Foscarnet; Gentamicins; Kidney; Kinetics; Lipid Metabolism; Male; Microvilli; Phosphonoacetic Acid; Rats; Rats, Inbred Strains; Sodium-Hydrogen Exchangers; Sodium-Phosphate Cotransporter Proteins; Symporters | 1990 |
Nephrogenic diabetes insipidus associated with foscarnet treatment of cytomegalovirus retinitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Diabetes Insipidus; Eye Infections, Viral; Foscarnet; Humans; Kidney Diseases; Male; Phosphonoacetic Acid; Retinitis | 1990 |
Fixed drug eruption due to foscarnet.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Drug Eruptions; Foscarnet; Humans; Male; Penile Diseases; Phosphonoacetic Acid | 1990 |
Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Drug Resistance, Microbial; Female; Foscarnet; Herpes Simplex; Humans; Male; Phosphonoacetic Acid; Risk Factors; Simplexvirus; Vidarabine | 1990 |
Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease.
Topics: Acyclovir; Antiviral Agents; Foscarnet; Ganciclovir; Humans; Idoxuridine; Keratitis, Dendritic; Microbial Sensitivity Tests; Phosphonoacetic Acid; Simplexvirus; Vidarabine | 1990 |
Acyclovir-resistant herpes simplex virus causing pneumonia after marrow transplantation.
Topics: Acyclovir; Adult; Animals; Antiviral Agents; Bone Marrow Transplantation; Cells, Cultured; Drug Resistance, Microbial; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Herpes Simplex; Humans; Male; Middle Aged; Phosphonoacetic Acid; Pneumonia, Viral; Simplexvirus; Thymidine Kinase; Vero Cells; Vidarabine | 1990 |
Prevention of foscarnet nephrotoxicity.
Topics: Adult; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Female; Fluid Therapy; Foscarnet; Humans; Kidney Diseases; Male; Phosphonoacetic Acid; Sodium Chloride | 1990 |
Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Aphidicolin; Deoxyguanosine; Diterpenes; Drug Resistance, Microbial; Female; Foscarnet; Herpes Simplex; Humans; Phosphonoacetic Acid; Simplexvirus | 1990 |
Inhibitory effects of potent inhibitors of human immunodeficiency virus and cytomegalovirus on the growth of human granulocyte-macrophage progenitor cells in vitro.
Topics: Adenine; Adult; Antiviral Agents; Bone Marrow; Bone Marrow Cells; Cells, Cultured; Cidofovir; Cytomegalovirus; Cytosine; Foscarnet; Ganciclovir; Granulocytes; Hematopoietic Stem Cells; HIV; Humans; Macrophages; Organophosphonates; Organophosphorus Compounds; Phosphonoacetic Acid; Zidovudine | 1990 |
Wider access provided to AIDS drugs with actions against HIV, CMV infections.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; HIV Infections; Humans; Phosphonoacetic Acid; Zalcitabine | 1990 |
Epstein-Barr virus-carrying B cells in the blood during acute infectious mononucleosis give rise to lymphoblastoid lines in vitro by release of transforming virus and by proliferation.
Topics: Acute Disease; Adolescent; Adult; Antibodies, Viral; Antigens, Viral; B-Lymphocytes; Capsid Proteins; Cell Transformation, Viral; Cells, Cultured; Epstein-Barr Virus Nuclear Antigens; Foscarnet; Herpesvirus 4, Human; Humans; Infectious Mononucleosis; Lymphocyte Activation; Phosphonoacetic Acid; Saliva | 1990 |
Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate.
Topics: Cell Line; Deltaretrovirus; Dose-Response Relationship, Drug; Foscarnet; Humans; Organophosphorus Compounds; Phosphonoacetic Acid; RNA-Directed DNA Polymerase; Time Factors; Virus Replication | 1985 |
Inhibition of HTLV-III/LAV replication by foscarnet.
Topics: Antiviral Agents; Deltaretrovirus; Foscarnet; Humans; Organophosphorus Compounds; Phosphonoacetic Acid; RNA-Directed DNA Polymerase; Virus Replication | 1985 |
PPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptase.
Topics: Antiviral Agents; Avian Myeloblastosis Virus; Deltaretrovirus; Foscarnet; Humans; Phosphates; Phosphonoacetic Acid; Reverse Transcriptase Inhibitors | 1986 |
RNA-dependent DNA polymerase activity in Paramecium tetraurelia: what for?
Topics: Animals; Antimony; Avian Myeloblastosis Virus; Cell Cycle; Centrifugation, Density Gradient; Dose-Response Relationship, Drug; Ethidium; Foscarnet; Magnesium; Manganese; Paramecium; Phosphonoacetic Acid; RNA-Directed DNA Polymerase; Suramin; Templates, Genetic; Tungsten; Tungsten Compounds | 1987 |
Visna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosides.
Topics: Antimetabolites; Antiviral Agents; Deoxyribonucleosides; Deoxyribonucleotides; Foscarnet; HIV; Organophosphorus Compounds; Phosphonoacetic Acid; Reverse Transcriptase Inhibitors; Ribavirin; Ribonucleosides; Virus Replication; Visna-maedi virus | 1987 |
Inhibition of HIV-1 RNA-dependent DNA polymerase and cellular DNA polymerases alpha, beta and gamma by phosphonoformic acid and other drugs.
Topics: Antiviral Agents; DNA Polymerase I; DNA Polymerase II; DNA Polymerase III; Foscarnet; HIV; In Vitro Techniques; Microbial Sensitivity Tests; Nucleic Acid Synthesis Inhibitors; Organophosphorus Compounds; Phosphonoacetic Acid; Reverse Transcriptase Inhibitors | 1988 |
HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Dideoxynucleosides; Drug Resistance; Foscarnet; HeLa Cells; HIV; HIV Core Protein p24; Humans; Microbial Sensitivity Tests; Phosphonoacetic Acid; Retroviridae Proteins; Reverse Transcriptase Inhibitors; Viral Plaque Assay; Virus Replication; Zalcitabine; Zidovudine | 1989 |
In vitro evaluation of mismatched double-stranded RNA (ampligen) for combination therapy in the treatment of acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Alkaloids; Amphotericin B; Antiviral Agents; Drug Therapy, Combination; Foscarnet; HIV; Humans; In Vitro Techniques; Indolizines; Interferon beta-1a; Interferon beta-1b; Interferon Type I; Interferon-beta; Interferon-gamma; Interferons; Microbial Sensitivity Tests; Phosphonoacetic Acid; Recombinant Proteins; Ribavirin; RNA, Double-Stranded; Zidovudine | 1989 |
Infectious potential of human immunodeficiency virus type 1 reverse transcriptase mutants with altered inhibitor sensitivity.
Topics: Amino Acid Sequence; Antiviral Agents; Cell Line; Cloning, Molecular; Escherichia coli; Foscarnet; Genes; Genes, Viral; HIV-1; Humans; Molecular Sequence Data; Mutation; Phosphonoacetic Acid; Recombinant Proteins; RNA-Directed DNA Polymerase; Transfection; Zidovudine | 1989 |
Reverse transcriptases from human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus (SIVMAC) are susceptible to inhibition by foscarnet and 3'-azido-3'-deoxythymidine triphosphate.
Topics: Animals; Dideoxynucleotides; Foscarnet; HIV-1; HIV-2; Humans; Organophosphorus Compounds; Phosphonoacetic Acid; Reverse Transcriptase Inhibitors; Simian Immunodeficiency Virus; Thymine Nucleotides; Zidovudine | 1988 |
Inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxynucleoside triphosphates: template dependence, and combination with phosphonoformate.
Topics: Acquired Immunodeficiency Syndrome; Dideoxynucleosides; Dinucleoside Phosphates; DNA Replication; DNA, Viral; Drug Combinations; Foscarnet; HIV; Kinetics; Organophosphorus Compounds; Phosphonoacetic Acid; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Substrate Specificity; Templates, Genetic; Virus Replication | 1989 |
Inhibition of RNA- and DNA-dependent duck hepatitis B virus DNA polymerase activity by nucleoside and pyrophosphate analogs.
Topics: Animals; Antiviral Agents; Chick Embryo; Diphosphates; DNA-Directed DNA Polymerase; Foscarnet; Hepatitis B Virus, Duck; Nucleic Acid Synthesis Inhibitors; Nucleotides; Phosphonoacetic Acid; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase | 1989 |
[New therapeutic possibilities in fulminant viral hepatitis].
Topics: Foscarnet; Hepatitis, Viral, Human; Humans; Liver Transplantation; Phosphonoacetic Acid; Prognosis | 1989 |
Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trial.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Herpes Simplex; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Organophosphorus Compounds; Phosphonoacetic Acid | 1989 |
Na+ and pH dependent transport of foscarnet via the phosphate carrier system across intestinal brush-border membrane.
Topics: Animals; Biological Transport; Carrier Proteins; Foscarnet; Hydrogen-Ion Concentration; Intestinal Absorption; Intestinal Mucosa; Male; Microvilli; Organophosphorus Compounds; Osmolar Concentration; Phosphate-Binding Proteins; Phosphates; Phosphonoacetic Acid; Rats; Rats, Inbred Strains; Sodium; Time Factors | 1989 |
Effects of phosphonoformic and phosphonoacetic acids on developing enamel of rat molars.
Topics: Ameloblasts; Amelogenesis; Animals; Calcinosis; Dental Enamel; Dental Enamel Hypoplasia; Female; Foscarnet; Male; Microscopy, Electron, Scanning; Molar; Organophosphorus Compounds; Phosphonoacetic Acid; Rats; Rats, Inbred Strains | 1989 |
"Body burden" of phosphonoformic acid after topical and vaginal administration to rabbits and beagle dogs.
Topics: Administration, Intravaginal; Administration, Oral; Administration, Topical; Animals; Antiviral Agents; Biological Availability; Body Burden; Dogs; Female; Foscarnet; Injections, Intravenous; Organophosphorus Compounds; Phosphonoacetic Acid; Rabbits | 1989 |
Different mechanisms of adaptive increase in Na+-Pi cotransport across renal brush-border membrane.
Topics: Adaptation, Physiological; Animals; Biomechanical Phenomena; Carrier Proteins; Cycloheximide; Dactinomycin; Diet; Foscarnet; Kidney; Kinetics; Male; Membrane Fluidity; Microvilli; Phlorhizin; Phosphates; Phosphonoacetic Acid; Phosphorus; Rats; Rats, Inbred Strains; Sodium-Phosphate Cotransporter Proteins; Symporters; Triiodothyronine | 1989 |
Comparison of foscarnet and foscarnet esters as anti-influenza virus agents.
Topics: Antiviral Agents; Cell Nucleus; Cells, Cultured; Foscarnet; Influenza A virus; Organophosphorus Compounds; Phosphonoacetic Acid; RNA, Viral | 1989 |
Acyclovir-resistant, foscarnet-sensitive oral herpes simplex type 2 lesion in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Candidiasis, Oral; Drug Resistance, Microbial; Facial Dermatoses; Foscarnet; Herpes Simplex; Humans; Male; Organophosphorus Compounds; Phosphonoacetic Acid; Stomatitis, Herpetic | 1989 |
Dexamethasone blocks adaptive increase of Na+-Pi cotransport in renal brush border membrane elicited by thyroid hormone.
Topics: Animals; Carrier Proteins; Dexamethasone; Foscarnet; Kidney; Male; Microvilli; Parathyroid Glands; Phosphates; Phosphonoacetic Acid; Rats; Rats, Inbred Strains; Sodium-Phosphate Cotransporter Proteins; Symporters; Thyroidectomy; Triiodothyronine | 1989 |
Determination of phosphonoformate (foscarnet) in biological fluids by ion-pair reversed-phase liquid chromatography.
Topics: Chromatography, High Pressure Liquid; Foscarnet; Humans; Organophosphorus Compounds; Phosphonoacetic Acid; Spectrophotometry, Ultraviolet | 1989 |
Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnet.
Topics: Antiviral Agents; Cells, Cultured; Fluorescent Antibody Technique; Foscarnet; HIV-1; Humans; Organophosphorus Compounds; Phosphonoacetic Acid; Zidovudine | 1989 |
Effect of phosphonoformic acid, dietary phosphate and the Hyp mutation on kinetically distinct phosphate transport processes in mouse kidney.
Topics: Animals; Biological Transport; Diet; Female; Foscarnet; Kidney; Kinetics; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Microvilli; Mutation; Organophosphorus Compounds; Phosphates; Phosphonoacetic Acid | 1989 |
Pharmacokinetics of foscarnet and distribution to cerebrospinal fluid after intravenous infusion in patients with human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Creatine; Foscarnet; Humans; Infusions, Intravenous; Male; Organophosphorus Compounds; Phosphonoacetic Acid | 1989 |
Foscarnet therapy in chronic hepatitis B virus E antigen carriers.
Topics: Adult; Antiviral Agents; Carrier State; DNA, Viral; Foscarnet; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Male; Phosphonoacetic Acid; Pilot Projects; Virus Replication | 1989 |
Comparative assessment of antiretrovirals in human monocyte-macrophages and lymphoid cell lines acutely and chronically infected with the human immunodeficiency virus.
Topics: Antiviral Agents; Dose-Response Relationship, Drug; Foscarnet; Gene Products, gag; HIV; HIV Antigens; HIV Core Protein p24; Humans; Interferon Type I; Macrophages; Monocytes; Phosphonoacetic Acid; RNA, Viral; Tumor Cells, Cultured; Viral Core Proteins; Virus Replication; Zidovudine | 1989 |
Structure-activity relationships of fluorinated nucleoside analogs and their synergistic effect in combination with phosphonoformate against human immunodeficiency virus type 1.
Topics: Antiviral Agents; Cells, Cultured; Dideoxynucleosides; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Foscarnet; HIV-1; Humans; Phosphonoacetic Acid; Structure-Activity Relationship; Virus Replication; Zidovudine | 1989 |
Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Drug Resistance, Microbial; Female; Foscarnet; Herpes Genitalis; Herpes Simplex; Humans; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Skin Diseases, Infectious | 1989 |
[Chemotherapy of cytomegalovirus infections].
Topics: Acyclovir; Adenine; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Phosphonoacetic Acid | 1989 |
[Diagnosis and treatment of cytomegalovirus infections].
Topics: Acyclovir; Antigens, Viral; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Female; Foscarnet; Ganciclovir; Humans; Infant, Newborn; Phosphonoacetic Acid; Pregnancy; Serologic Tests | 1989 |
Foscarnet in the treatment of cytomegalovirus retinitis in acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Creatine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Foscarnet; Humans; Infusions, Intravenous; Male; Middle Aged; Organophosphorus Compounds; Phosphonoacetic Acid; Retinitis; Time Factors; Visual Acuity; Zidovudine | 1989 |
Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro.
Topics: Antiviral Agents; Cells, Cultured; Cytomegalovirus; DNA-Directed DNA Polymerase; Drug Synergism; Foscarnet; HIV-1; Humans; Monocytes; Organophosphorus Compounds; Phosphonoacetic Acid; Viral Plaque Assay; Virus Replication; Zidovudine | 1989 |
Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Calcium; Cytomegalovirus Infections; Foscarnet; Humans; Injections, Intravenous; Organophosphorus Compounds; Parathyroid Hormone; Phosphonoacetic Acid; Phosphorus; Retinitis | 1989 |
Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Half-Life; Humans; Infusions, Intravenous; Organophosphorus Compounds; Phosphonoacetic Acid; Retinitis | 1989 |
In vitro mutagenesis of the herpes simplex virus type 1 DNA polymerase gene results in altered drug sensitivity of the enzyme.
Topics: Amino Acid Sequence; Antiviral Agents; Aphidicolin; Asparagine; Base Sequence; Diterpenes; DNA-Directed DNA Polymerase; Foscarnet; Genes, Viral; Genetic Vectors; HeLa Cells; Humans; Kinetics; Molecular Sequence Data; Mutation; Nucleic Acid Synthesis Inhibitors; Oligonucleotide Probes; Phosphonoacetic Acid; Saccharomyces cerevisiae; Serine; Simplexvirus; Viral Structural Proteins | 1989 |
Foscarnet nephrotoxicity: mechanism, incidence and prevention.
Topics: Acute Kidney Injury; Adult; Aged; Cohort Studies; Creatinine; Cytomegalovirus Infections; Fluid Therapy; Foscarnet; Humans; Male; Middle Aged; Phosphonoacetic Acid; Retrospective Studies | 1989 |
Foscarnet prophylaxis in marrow transplant recipients.
Topics: Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Humans; Nucleic Acid Synthesis Inhibitors; Phosphonoacetic Acid; Virus Replication | 1989 |
Evaluation by immune scanning electron microscopy of foscarnet treatment of cytomegalovirus infection in patients with renal transplants.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cytomegalovirus; Cytomegalovirus Infections; Drug Evaluation; Foscarnet; Humans; Incidence; Kidney Transplantation; Microscopy, Electron, Scanning; Middle Aged; Pancreas Transplantation; Phosphonoacetic Acid | 1989 |
Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo.
Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Cytomegalovirus; Dose-Response Relationship, Drug; Drug Synergism; Female; Foscarnet; Ganciclovir; Humans; Mice; Phosphonoacetic Acid; Rats; Simplexvirus; Viral Plaque Assay | 1989 |
Tubulointerstitial nephritis caused by the antiviral agent foscarnet.
Topics: Adult; Antiviral Agents; Cytomegalovirus Infections; Female; Foscarnet; Humans; Kidney Transplantation; Male; Middle Aged; Nephritis, Interstitial; Phosphonoacetic Acid | 1989 |
Foscarnet infusion at home.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Drug Administration Schedule; Foscarnet; Home Care Services; Humans; Infusions, Intravenous; Male; Organophosphorus Compounds; Phosphonoacetic Acid; Retinitis | 1989 |
Susceptibility of human herpesvirus 6 to acyclovir and ganciclovir.
Topics: Acyclovir; Antiviral Agents; Foscarnet; Ganciclovir; Herpesviridae; Humans; Microbial Sensitivity Tests; Phosphonoacetic Acid | 1989 |
Immunological characterization of an early cytomegalovirus single-strand DNA-binding protein with similarities to the HSV major DNA-binding protein.
Topics: Cell Compartmentation; Cross Reactions; Cytomegalovirus; DNA-Binding Proteins; DNA, Single-Stranded; Fluorescent Antibody Technique; Foscarnet; Immunosorbent Techniques; Nuclear Proteins; Phosphonoacetic Acid; Simplexvirus; Viral Proteins; Virus Replication | 1987 |
Treatment of CMV retinitis in an AIDS patient.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Male; Middle Aged; Phosphonoacetic Acid; Retina; Retinitis; Visual Acuity | 1987 |
Aerosol administration of antiviral agents to treat lung infection due to murine cytomegalovirus.
Topics: Acyclovir; Administration, Oral; Aerosols; Animals; Antiviral Agents; Cytomegalovirus Infections; Disease Models, Animal; Female; Foscarnet; Ganciclovir; Mice; Mice, Inbred BALB C; Phosphonoacetic Acid; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Ribavirin | 1988 |
Therapeutic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, caffeic acid oxidation product, and trisodiumphosphonoformate on cutaneous herpes simplex virus type 1 infection in guinea pigs.
Topics: Animals; Antiviral Agents; Bromodeoxyuridine; Caffeic Acids; Cinnamates; Female; Foscarnet; Guinea Pigs; Herpes Simplex; Humans; Male; Organophosphorus Compounds; Oxidation-Reduction; Phosphonoacetic Acid; Simplexvirus | 1987 |
Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (Foscarnet).
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Humans; Immunoblastic Lymphadenopathy; Male; Middle Aged; Organophosphorus Compounds; Phosphonoacetic Acid; Recurrence; Retinitis | 1988 |
[Cytomegaloviruses and antiviral agents--a review].
Topics: Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Humans; Phosphonoacetic Acid | 1988 |
Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
Topics: Acyclovir; Administration, Oral; Administration, Topical; Animals; Antiviral Agents; Disease Models, Animal; DNA Replication; DNA, Viral; Foscarnet; Herpes Simplex; Male; Mice; Nervous System Diseases; Organophosphorus Compounds; Phosphonoacetic Acid; Recurrence; Simplexvirus; Skin; Skin Diseases, Infectious; Virus Replication | 1988 |
Acute renal failure induced by foscarnet: 4 cases.
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adult; Antiviral Agents; Chorioretinitis; Cytomegalovirus Infections; Female; Foscarnet; Humans; Immune Tolerance; Male; Middle Aged; Organophosphorus Compounds; Phosphonoacetic Acid | 1988 |
Increased efficacy of phosphonoformate and phosphonoacetate inhibition of herpes simplex virus type 2 replication by encapsulation in liposomes.
Topics: Animals; Antiviral Agents; Cell Survival; Cells, Cultured; Cytopathogenic Effect, Viral; Foscarnet; Liposomes; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Vero Cells; Virus Replication | 1988 |
Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; HIV; HIV Antigens; Humans; Infusions, Intravenous; Leukocytes, Mononuclear; Organophosphorus Compounds; Phosphonoacetic Acid; Retinitis | 1988 |
Failure of antiviral therapy for acquired immunodeficiency syndrome-related cytomegalovirus myelitis.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Cytomegalovirus Infections; Encephalomyelitis; Foscarnet; Ganciclovir; Humans; Male; Organophosphorus Compounds; Phosphonoacetic Acid | 1988 |
Primate cytomegalovirus assembly: evidence that DNA packaging occurs subsequent to B capsid assembly.
Topics: Capsid; Cells, Cultured; Centrifugation, Density Gradient; Cytomegalovirus; DNA, Viral; Electrophoresis, Polyacrylamide Gel; Fibroblasts; Foscarnet; Humans; Hydroxyurea; Microscopy, Electron; Phosphonoacetic Acid; Virion | 1988 |
Mechanism of phosphaturia elicited by administration of phosphonoformate in vivo.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Absorption; Adenylyl Cyclases; Animals; Blood Pressure; Cyclic AMP; Foscarnet; Glomerular Filtration Rate; Kidney; Kidney Tubules, Proximal; Male; Microvilli; Natriuresis; Organophosphorus Compounds; Parathyroid Hormone; Phosphates; Phosphonoacetic Acid; Rats; Rats, Inbred Strains; Sodium | 1988 |
Foscarnet as treatment for cytomegalovirus retinitis following bone marrow transplantation.
Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; Busulfan; Cataract; Cytomegalovirus Infections; Foscarnet; Humans; Immunosuppression Therapy; Male; Organophosphorus Compounds; Phosphonoacetic Acid; Retinitis | 1988 |
Interaction of Epstein-Barr virus DNA polymerase with aphidicolin, phosphonoformate and 5'-GMP.
Topics: Aphidicolin; Deoxyribonucleotides; Diterpenes; Foscarnet; Guanine Nucleotides; Guanosine Monophosphate; Herpesvirus 4, Human; Nucleic Acid Synthesis Inhibitors; Organophosphorus Compounds; Phosphonoacetic Acid; Protein Binding; Viral Proteins | 1988 |
Antiherpesvirus activity and mechanism of action of indolo-(2,3-b)quinoxaline and analogs.
Topics: Acyclovir; Animals; Antigens, Viral; Antiviral Agents; Cell Line; Cytomegalovirus; DNA-Directed DNA Polymerase; DNA, Viral; Drug Evaluation, Preclinical; Foscarnet; Herpesvirus 3, Human; Humans; Indoles; Nucleic Acid Hybridization; Phosphonoacetic Acid; Quinoxalines; Simplexvirus; Structure-Activity Relationship; Tumor Cells, Cultured; Virus Replication | 1988 |
Efficacy of 5-vinyl-1-beta-D-arabinofuranosyluracil (VaraU) against herpes simplex virus type 2 strains in cell cultures and against experimental herpes encephalitis in mice: comparison with acyclovir and foscarnet.
Topics: Acyclovir; Animals; Antiviral Agents; Arabinofuranosyluracil; Cells, Cultured; Encephalitis; Female; Foscarnet; Herpes Simplex; Mice; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Uridine; Virus Replication | 1987 |
Sensitivity of HSV clinical isolates to foscarnet and in vitro dual combination of foscarnet and acyclovir.
Topics: Acyclovir; Antiviral Agents; Drug Interactions; Foscarnet; Herpes Labialis; Humans; Microbial Sensitivity Tests; Neutral Red; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Viral Plaque Assay | 1987 |
Foscarnet for cytomegalovirus pneumonitis.
Topics: Adult; Cytomegalovirus Infections; Foscarnet; Humans; Male; Organophosphorus Compounds; Phosphonoacetic Acid; Pneumonia, Viral | 1985 |
Foscarnet for cytomegalovirus infections.
Topics: Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Humans; Organophosphorus Compounds; Phosphonoacetic Acid | 1985 |
Foscarnet.
Topics: Animals; Antiviral Agents; Deltaretrovirus; Foscarnet; Humans; Organophosphorus Compounds; Phosphonoacetic Acid; Virus Diseases | 1985 |
In vitro effect of foscarnet on expansion of T-cells from people with LAS and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Colony-Forming Units Assay; Deltaretrovirus; Foscarnet; Humans; Lymphatic Diseases; Organophosphorus Compounds; Phosphonoacetic Acid; Retroviridae Infections; Syndrome; T-Lymphocytes | 1985 |
Herpes simplex virus hepatitis in mice: effects of treatment with trisodium phosphonoformate.
Topics: Animals; Antiviral Agents; Disease Models, Animal; Foscarnet; Hepatitis, Viral, Animal; Herpes Simplex; Liver; Mice; Necrosis; Organophosphorus Compounds; Phosphonoacetic Acid | 1985 |
Foscarnet in fulminant hepatitis B.
Topics: Adolescent; Antiviral Agents; Foscarnet; Hepatic Encephalopathy; Hepatitis B; Humans; Organophosphorus Compounds; Phosphonoacetic Acid | 1986 |
Foscarnet-induced acute renal failure and effectiveness of haemodialysis.
Topics: Acute Kidney Injury; Female; Foscarnet; Humans; Middle Aged; Organophosphorus Compounds; Phosphonoacetic Acid; Renal Dialysis | 1987 |
Declining levels of HIV P24 antigen in serum during treatment with foscarnet.
Topics: Acquired Immunodeficiency Syndrome; Antigens, Viral; Antiviral Agents; Foscarnet; HIV; HIV Antigens; HIV Core Protein p24; Humans; Male; Organophosphorus Compounds; Phosphonoacetic Acid; Retroviridae Proteins | 1988 |
Severe hypocalcaemia in AIDS patients treated with foscarnet and pentamidine.
Topics: Acquired Immunodeficiency Syndrome; Amidines; Foscarnet; Humans; Hypocalcemia; Organophosphorus Compounds; Pentamidine; Phosphonoacetic Acid | 1988 |
Acyclovir-resistant herpes in AIDS treated with foscarnet.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Drug Resistance, Microbial; Female; Foscarnet; Herpes Genitalis; Humans; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Thymidine; Zidovudine | 1988 |
Herpes simplex type 1 defective interfering particles do not affect the antiviral activity of acyclovir, foscarnet and adenine arabinoside.
Topics: Acyclovir; Animals; Defective Viruses; Foscarnet; Organophosphorus Compounds; Phosphonoacetic Acid; Serial Passage; Simplexvirus; Vidarabine | 1988 |
Foscarnet infusion at home.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cytomegalovirus Infections; Foscarnet; HIV Antigens; Home Care Services; Humans; Infusions, Intravenous; Male; Organophosphorus Compounds; Phosphonoacetic Acid; Retinitis | 1988 |
In vitro effect of acyclovir and other antiherpetic compounds on the replication of channel catfish virus.
Topics: Acyclovir; Animals; Antiviral Agents; Cell Line; DNA Replication; Fishes; Foscarnet; Herpesviridae; Kinetics; Phosphonoacetic Acid; Vidarabine; Viral Plaque Assay; Virus Replication | 1985 |
Concentration-dependent effects of foscarnet on the cell cycle.
Topics: Antiviral Agents; Biological Transport; Cell Cycle; Cell Division; Cell Line; Cell Membrane Permeability; DNA; Embryo, Mammalian; Fibroblasts; Foscarnet; Humans; Interphase; Kinetics; Organophosphorus Compounds; Phosphonoacetic Acid | 1985 |
Selection and characterization of mutant S49 T-lymphoma cell lines resistant to phosphonoformic acid: evidence for inhibition of ribonucleotide reductase.
Topics: Animals; Cell Cycle; Cell Division; Cell Line; Clone Cells; Deoxyribonucleotides; Drug Resistance; Flow Cytometry; Foscarnet; Lymphoma; Mice; Mutation; Nucleotides; Organophosphorus Compounds; Phosphonoacetic Acid; Ribonucleotide Reductases | 1986 |
Foscarnet decreases serum and liver duck hepatitis B virus DNA in chronically infected ducks.
Topics: Animals; Antiviral Agents; DNA, Viral; Dose-Response Relationship, Drug; Ducks; Enterovirus Infections; Foscarnet; Hepatitis B; Hepatitis B virus; Organophosphorus Compounds; Phosphonoacetic Acid | 1986 |
Comparison of foscarnet cream, acyclovir cream, and acyclovir ointment in the topical treatment of experimental cutaneous herpes simplex virus type 1 infection.
Topics: Acyclovir; Administration, Topical; Animals; Female; Foscarnet; Guinea Pigs; Herpes Simplex; Ointments; Organophosphorus Compounds; Phosphonoacetic Acid | 1986 |
The effect of phosphonoformic acid on wild type and mutant S49 cell lines.
Topics: Animals; Cell Cycle; Cell Line; Cytidine Diphosphate; Deoxyribonucleotides; DNA Polymerase II; Drug Resistance; Foscarnet; Mice; Mutation; Nucleotides; Organophosphorus Compounds; Phosphonoacetic Acid; Ribonucleotide Reductases | 1986 |
Inhibition of human renal epithelial Na+/Pi cotransport by phosphonoformic acid.
Topics: Animals; Biological Transport, Active; Cells, Cultured; Dose-Response Relationship, Drug; Epithelium; Foscarnet; Humans; Kidney Cortex; Kinetics; Microvilli; Organophosphorus Compounds; Phosphates; Phosphonoacetic Acid; Rats; Sodium | 1986 |
Antiviral activity of 5'-PAA and 5'-PFA phosphate esters of 2'-deoxyuridines.
Topics: Animals; Antiviral Agents; Bromodeoxyuridine; Cell Survival; Foscarnet; Phosphonoacetic Acid; Structure-Activity Relationship; Thymidine Kinase; Vero Cells | 1986 |
Effect of sodium phosphonoformate on blood group antibody detection.
Topics: Acquired Immunodeficiency Syndrome; Antibodies; Blood Grouping and Crossmatching; Coombs Test; Foscarnet; Hepatitis B Surface Antigens; Humans; Organophosphorus Compounds; Phosphonoacetic Acid | 1986 |
Inhibition of Na+-Pi cotransporter in small gut brush border by phosphonocarboxylic acids.
Topics: Animals; Biological Transport; Carrier Proteins; Foscarnet; Intestine, Small; Kinetics; Male; Microvilli; Organophosphorus Compounds; Phosphates; Phosphonoacetic Acid; Potassium; Rats; Rats, Inbred Strains; Sodium; Sodium-Phosphate Cotransporter Proteins; Symporters | 1987 |
AIDS: the virus, antivirals and vaccines.
Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; Genes, Viral; HIV; Humans; Phosphonoacetic Acid; Suramin; Thymidine; Tungsten; Tungsten Compounds; Viral Vaccines; Virus Replication; Zidovudine | 1987 |
Interactions of [14C]phosphonoformic acid with renal cortical brush-border membranes. Relationship to the Na+-phosphate co-transporter.
Topics: Animals; Anions; Antiviral Agents; Carbon Radioisotopes; Carrier Proteins; Cations, Monovalent; Foscarnet; Kidney Cortex; Kinetics; Male; Mannitol; Microvilli; Organophosphorus Compounds; Phosphonoacetic Acid; Protein Binding; Rats; Rats, Inbred Strains; Sodium-Phosphate Cotransporter Proteins; Symporters | 1987 |
Screening of antiviral drugs for treatment of hepatitis B.
Topics: Acyclovir; Animals; Antiviral Agents; Drug Evaluation, Preclinical; Ducks; Foscarnet; Hepatitis B; Humans; Organophosphorus Compounds; Phosphonoacetic Acid; Suramin | 1986 |
Chronic herpetic infection in an immunocompromised patient: report of a case.
Topics: Acyclovir; Antiviral Agents; Bromodeoxyuridine; Chronic Disease; Foscarnet; Humans; Immunosuppression Therapy; Leukemia, Lymphoid; Male; Middle Aged; Phosphonoacetic Acid; Stomatitis, Herpetic; Vidarabine | 1987 |
Treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection with foscarnet.
Topics: Acute Disease; Adolescent; Adult; Antiviral Agents; Female; Foscarnet; Hepatitis B; Hepatitis D; Humans; Organophosphorus Compounds; Phosphonoacetic Acid | 1987 |
Effect of sodium phosphonoformate on blood group antibody detection.
Topics: Blood Group Antigens; Foscarnet; Humans; Isoantibodies; Organophosphorus Compounds; Phosphonoacetic Acid | 1987 |
The effects of topical foscarnet in a new model of herpes simplex skin infection.
Topics: Administration, Cutaneous; Animals; Antiviral Agents; Disease Models, Animal; Foscarnet; Herpes Simplex; Humans; Male; Mice; Mice, Nude; Organophosphorus Compounds; Phosphonoacetic Acid; Skin Transplantation; Transplantation, Heterologous | 1987 |
Synergistic inhibition of anatid herpesvirus replication by acyclovir and phosphonocompounds.
Topics: Acyclovir; Animals; Deoxycytidine; Drug Interactions; Drug Resistance, Microbial; Foscarnet; Herpesviridae; Mutation; Organophosphorus Compounds; Phosphonoacetic Acid; Thymidine; Virus Replication | 1987 |
Pharmacokinetics and absorption of foscarnet after intravenous and oral administration to patients with human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Bone and Bones; Calcium; Foscarnet; Glomerular Filtration Rate; Half-Life; Humans; Infusions, Intravenous; Kidney Tubules; Male; Metabolic Clearance Rate; Organophosphorus Compounds; Phosphates; Phosphonoacetic Acid | 1988 |
In vitro inhibition of human herpesvirus-6 by phosphonoformate.
Topics: Acyclovir; Antiviral Agents; Cell Line; Foscarnet; Ganciclovir; Herpesviridae; Humans; Organophosphorus Compounds; Phosphonoacetic Acid | 1988 |
Influence of dimethylacetamide, N-N-diethyl-m-toluamide and 1-dodecylazacycloheptan-2-one on ex vivo permeation of phosphonoformic acid through rat skin.
Topics: Acetamides; Animals; Antiviral Agents; Azepines; Benzamides; Cryoprotective Agents; DEET; Foscarnet; In Vitro Techniques; Male; Organophosphorus Compounds; Phosphonoacetic Acid; Rats; Rats, Inbred Strains; Skin Absorption | 1988 |
Toxicity of intravitreal injection of foscarnet in the rabbit eye.
Topics: Animals; Foscarnet; Injections; Intraocular Pressure; Ophthalmoscopy; Organophosphorus Compounds; Phosphonoacetic Acid; Rabbits; Retina; Vitreous Body | 1988 |
Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus.
Topics: Acyclovir; Antiviral Agents; Arabinofuranosyluracil; Arabinonucleosides; Bromodeoxyuridine; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Genes, Viral; Idoxuridine; Mutation; Phosphonoacetic Acid; Simplexvirus; Thymidine; Vidarabine | 1985 |
Antiviral activity of CP-20,961 against herpes simplex viruses in vitro.
Topics: Acyclovir; Animals; Bromodeoxyuridine; Cells, Cultured; Diamines; Embryo, Mammalian; Foscarnet; Guinea Pigs; Phosphonoacetic Acid; Rabbits; Simplexvirus | 1985 |
Distinctive properties of DNA polymerases induced by herpes simplex virus type-1 and Epstein-Barr virus.
Topics: Animals; Aphidicolin; Cell Line; Chromatography, DEAE-Cellulose; Diterpenes; DNA-Directed DNA Polymerase; Ethylmaleimide; Foscarnet; Herpesvirus 4, Human; Hot Temperature; Nucleic Acid Synthesis Inhibitors; Nucleosides; Phosphonoacetic Acid; Simplexvirus | 1985 |
Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with trifluorothymidine, phosphonoformate and acycloguanosine against herpes simplex viruses.
Topics: Acyclovir; Animals; Antiviral Agents; Deoxyuridine; DNA, Viral; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Encephalitis; Foscarnet; Herpes Simplex; Male; Mice; Organophosphorus Compounds; Phosphonoacetic Acid; Rabbits; Simplexvirus; Thymidine; Trifluridine; Vidarabine; Virus Replication | 1985 |
Mutually exclusive inhibition of herpesvirus DNA polymerase by aphidicolin, phosphonoformate, and acyclic nucleoside triphosphates.
Topics: Acyclovir; Antiviral Agents; Aphidicolin; Deoxyribonucleases; Diterpenes; Foscarnet; Guanosine Triphosphate; Kinetics; Nucleic Acid Synthesis Inhibitors; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus | 1985 |
Multiplicity dependence and sensitivity of herpes simplex virus isolates to antiviral compounds.
Topics: Acyclovir; Antiviral Agents; Cells, Cultured; Foscarnet; Humans; Idoxuridine; Microbial Sensitivity Tests; Phosphonoacetic Acid; Simplexvirus; Vidarabine | 1985 |
Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipients.
Topics: Adult; Bone Marrow Transplantation; Child; Cytomegalovirus Infections; Female; Foscarnet; Humans; Immunosuppression Therapy; Infusions, Parenteral; Kidney Transplantation; Male; Middle Aged; Organophosphorus Compounds; Phosphonoacetic Acid | 1985 |
Demonstration of a stimulatory protein for virus-specified DNA polymerase in phorbol ester-treated Epstein-Barr virus-carrying cells.
Topics: Carcinoma; Cell Line; DNA-Directed DNA Polymerase; Enzyme Activation; Foscarnet; Herpesvirus 4, Human; Hot Temperature; Humans; Kinetics; Nasopharyngeal Neoplasms; Nucleic Acid Synthesis Inhibitors; Phosphonoacetic Acid; Potassium Chloride; Tetradecanoylphorbol Acetate; Viral Proteins | 1985 |
Induction of a deoxyuridine triphosphate nucleotidohydrolase activity in Epstein-Barr virus-infected cells.
Topics: Antiviral Agents; Burkitt Lymphoma; Cell Line; Cell Transformation, Viral; DNA Replication; Enzyme Induction; Foscarnet; Herpesvirus 4, Human; Humans; Kinetics; Phosphonoacetic Acid; Pyrophosphatases; Tetradecanoylphorbol Acetate; Virus Replication | 1985 |
Foscarnet for cytomegalovirus retinitis.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Humans; Male; Middle Aged; Organophosphorus Compounds; Phosphonoacetic Acid; Retinitis | 1985 |
Activity of the cytomegalovirus genome in the presence of PPi analogs.
Topics: Antiviral Agents; Cells, Cultured; Cytomegalovirus; Diphosphates; DNA Replication; DNA, Viral; Foscarnet; Humans; Nucleic Acid Synthesis Inhibitors; Organophosphorus Compounds; Phosphonoacetic Acid; Structure-Activity Relationship; Viral Proteins; Virus Replication | 1985 |
Inhibition of herpes simplex virus DNA polymerase by purine ribonucleoside monophosphates.
Topics: Antiviral Agents; Deoxyribonucleotides; DNA-Directed DNA Polymerase; Foscarnet; Guanosine Monophosphate; Kinetics; Nucleic Acid Synthesis Inhibitors; Phosphonoacetic Acid; Ribonucleotides; Simplexvirus; Viral Proteins | 1986 |
Clinical experiences with phosphonoformate (foscarnet) treatment of viral diseases following renal transplantation.
Topics: Adult; Aged; Antiviral Agents; Cytomegalovirus Infections; Female; Foscarnet; Herpes Simplex; Herpes Zoster; Humans; Immunosuppression Therapy; Kidney Transplantation; Male; Middle Aged; Organophosphorus Compounds; Phosphonoacetic Acid; Time Factors | 1985 |
Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients.
Topics: Adult; Aged; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Electrolytes; Female; Foscarnet; Humans; Kidney Transplantation; Kinetics; Liver Function Tests; Male; Middle Aged; Organophosphorus Compounds; Phosphonoacetic Acid | 1986 |
Phosphonocarboxylic acids as specific inhibitors of Na+-dependent transport of phosphate across renal brush border membrane.
Topics: Animals; Biological Transport, Active; Ca(2+) Mg(2+)-ATPase; Dogs; Dose-Response Relationship, Drug; Etidronic Acid; Foscarnet; Kidney; Kinetics; Male; Mice; Microvilli; Organophosphorus Compounds; Phosphates; Phosphonoacetic Acid; Proline; Rabbits; Rats; Rats, Inbred Strains; Sodium; Sodium-Potassium-Exchanging ATPase | 1986 |
Identification and characterization of a major early cytomegalovirus DNA-binding protein.
Topics: Cell Nucleus; Cells, Cultured; Cytomegalovirus; Deoxyribonuclease I; DNA-Binding Proteins; DNA, Single-Stranded; Foscarnet; Humans; Kinetics; Molecular Weight; Phosphonoacetic Acid; Viral Proteins | 1986 |
Epstein-Barr virus-specific DNA polymerase in virus-nonproducer Raji cells.
Topics: Antigens, Viral; Aphidicolin; Butyrates; Butyric Acid; Cell Line; Diterpenes; DNA Replication; DNA-Directed DNA Polymerase; Enzyme Induction; Foscarnet; Herpesvirus 4, Human; Humans; Phosphonoacetic Acid; Substrate Specificity; Tetradecanoylphorbol Acetate; Virus Replication | 1986 |
Deoxythymidine kinase, a possible marker for monitoring activity of cytomegalovirus infection after renal transplantation.
Topics: Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Humans; Kidney Transplantation; Male; Middle Aged; Phosphonoacetic Acid; Postoperative Complications; Retrospective Studies; Thymidine Kinase | 1986 |
Treatment of experimental herpes simplex virus type 1 encephalitis in mice with (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil: comparison with bromovinyl-deoxyuridine and acyclovir.
Topics: Acyclovir; Animals; Arabinofuranosyluracil; Bromodeoxyuridine; Cells, Cultured; Encephalitis; Female; Foscarnet; Herpes Simplex; Humans; Mice; Phosphonoacetic Acid; Simplexvirus; Uridine; Viral Plaque Assay | 1986 |
Interaction of DNA polymerase and nucleotide analog triphosphates.
Topics: Antiviral Agents; Binding, Competitive; DNA-Directed DNA Polymerase; Foscarnet; Humans; Kinetics; Nucleic Acid Synthesis Inhibitors; Nucleotides; Phosphonoacetic Acid; Simplexvirus; Structure-Activity Relationship; Virus Replication; Viruses | 1985 |
Serum thymidine kinase in transplant patients: its relation to cytomegalovirus activity, renal transplant rejection and its use for monitoring of antiviral therapy.
Topics: Adult; Antiviral Agents; Cell Division; Cytomegalovirus Infections; Female; Foscarnet; Graft Rejection; Humans; Immunosuppression Therapy; Kidney; Kidney Transplantation; Lymphocytes; Male; Phosphonoacetic Acid; Postoperative Period; Retrospective Studies; Thymidine Kinase | 1986 |
Synthesis and antiviral activity of certain nucleoside 5'-phosphonoformate derivatives.
Topics: Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Deltaretrovirus; Foscarnet; Hydrogen-Ion Concentration; Leukemia L1210; Leukemia P388; Mice; Nucleosides; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Structure-Activity Relationship | 1986 |
Synergistic inhibition of human T-cell lymphotropic virus type III replication in vitro by phosphonoformate and recombinant alpha-A interferon.
Topics: Cells, Cultured; Deltaretrovirus; Drug Synergism; Foscarnet; Humans; Interferon Type I; Lymphocytes; Organophosphorus Compounds; Phosphonoacetic Acid; Recombinant Proteins; Virus Replication | 1986 |
Comparative methods for detection of thymidine kinase-deficient herpes simplex virus type 1 strains.
Topics: Acyclovir; Antiviral Agents; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Foscarnet; Nucleic Acid Hybridization; Phosphonoacetic Acid; Simplexvirus; Thymidine Kinase; Viral Plaque Assay | 1986 |
Anti-herpes virus combinations in relation to drug resistance.
Topics: Acyclovir; Adenosine Deaminase Inhibitors; Animals; Antiviral Agents; Diphosphates; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Foscarnet; Herpes Simplex; In Vitro Techniques; Nucleic Acid Synthesis Inhibitors; Phosphonoacetic Acid; Simplexvirus; Thymidine Kinase; Uridine Phosphorylase; Vidarabine | 1986 |
[Importance of Foscarnet in the treatment of cytomegalovirus pneumopathy in a patient with acquired immunodeficiency syndrome].
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Humans; Lung Diseases; Male; Organophosphorus Compounds; Phosphonoacetic Acid | 1986 |
Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth.
Topics: B-Lymphocytes; Carrier State; Cyclosporins; Foscarnet; Herpesvirus 4, Human; Humans; Phosphonoacetic Acid | 1987 |
Synthesis of cytomegalovirus DNA is an antiviral target late in virus growth.
Topics: Acyclovir; Antiviral Agents; Cell Line; Cytomegalovirus; DNA, Viral; Floxuridine; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Spermidine; Spermine; Viral Proteins | 1987 |
[Prevention and treatment of cytomegalovirus infections after graft of allogenic bone marrow].
Topics: Acyclovir; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Phosphonoacetic Acid; Postoperative Complications | 1987 |
Treatment of cytomegalovirus pneumonitis with foscarnet (trisodium phosphonoformate) in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Humans; Male; Middle Aged; Organophosphorus Compounds; Phosphonoacetic Acid; Pneumonia, Viral | 1987 |
Pharmacokinetics of PFA (trisodium phosphonoformate) after i.v. and p.o. administration to beagle dogs and rabbits.
Topics: Administration, Oral; Animals; Antiviral Agents; Biological Availability; Dogs; Female; Foscarnet; Injections, Intravenous; Kinetics; Models, Biological; Organophosphorus Compounds; Phosphonoacetic Acid; Rabbits; Species Specificity | 1985 |
Nucleoside pools of acyclovir-treated herpes simplex type 1 infected cells.
Topics: Acyclovir; Animals; Cells, Cultured; Chlorocebus aethiops; Foscarnet; Herpes Simplex; Humans; Kinetics; Nucleosides; Phosphonoacetic Acid; Thymidine | 1985 |
Cutaneous herpes simplex virus infection of the guinea pig: lack of resistance to acyclovir and phosphonoformic acid after topical treatment.
Topics: Acyclovir; Administration, Topical; Animals; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Foscarnet; Guinea Pigs; Herpes Simplex; Male; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Skin Diseases, Infectious | 1984 |
Identification of a gene function of herpes simplex virus type 1 essential for amplification of simian virus 40 DNA sequences in transformed hamster cells.
Topics: Acyclovir; Animals; Cell Line; Cell Transformation, Viral; Centrifugation, Density Gradient; Cricetinae; DNA-Directed DNA Polymerase; DNA, Viral; Foscarnet; Gene Amplification; Genes, Viral; Mutation; Phosphonoacetic Acid; Simian virus 40; Simplexvirus; Temperature; Tunicamycin; Virus Replication | 1984 |
Induction of Epstein-Barr virus antigens and DNA-polymerase activities in P3HR-1 cell line and its subline passaged in the presence of phosphonoformate.
Topics: Antigens, Viral; Cell Line; DNA-Directed DNA Polymerase; Foscarnet; Herpesvirus 4, Human; Humans; Lymphoma; Nucleic Acid Synthesis Inhibitors; Organophosphorus Compounds; Phosphonoacetic Acid; Virus Activation; Virus Replication | 1983 |
Enrichment of early HSV-induced proteins in phosphonoformate-treated cells.
Topics: Antigens, Viral; DNA, Viral; Foscarnet; Gene Expression Regulation; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Viral Proteins; Virus Replication | 1984 |
Properties of antiviral agents. 1.
Topics: Acyclovir; Antiviral Agents; Bromodeoxyuridine; Evaluation Studies as Topic; Foscarnet; Herpesviridae; Humans; Idoxuridine; Phosphonoacetic Acid; Trifluridine; Vidarabine; Viruses | 1984 |
Observations on the phosphonoformic acid inhibition of RNA dependent DNA polymerases.
Topics: Diphosphates; Endonucleases; Foscarnet; Nucleic Acid Synthesis Inhibitors; Organophosphorus Compounds; Phosphonoacetic Acid; Pyridoxal Phosphate; Reverse Transcriptase Inhibitors; Ribonuclease H; Ribonucleases; Templates, Genetic | 1980 |
Inhibition of vesicular stomatitis virus transcriptase in vitro by phosphonoformate and ara-ATP.
Topics: Adenosine Triphosphate; Arabinonucleotides; Binding, Competitive; Foscarnet; Kinetics; Organophosphorus Compounds; Phosphonoacetic Acid; RNA Nucleotidyltransferases; RNA-Dependent RNA Polymerase; RNA, Viral; Time Factors; Transcription, Genetic; Vesicular stomatitis Indiana virus; Vidarabine Phosphate | 1980 |
Conditions for cytomegalovirus stimulation of lymphocytes.
Topics: Antibodies, Viral; Antigens, Viral; Antiviral Agents; Cells, Cultured; Cytomegalovirus; DNA Replication; DNA, Viral; Epitopes; Foscarnet; Humans; Lymphocyte Activation; Phosphonoacetic Acid; Phytohemagglutinins; Virus Replication | 1981 |
Differential inhibition of DNA polymerase and RNase H activities of the reverse transcriptase by phosphonoformate.
Topics: Animals; Cell Line; DNA, Viral; Endonucleases; Foscarnet; Kinetics; Mice; Nucleic Acid Synthesis Inhibitors; Organophosphorus Compounds; Phosphonoacetic Acid; Ribonuclease H; Ribonucleases; RNA-Directed DNA Polymerase; Virus Replication | 1982 |
Effects of acyclovir combined with other antiviral agents on human cytomegalovirus.
Topics: Acyclovir; Antiviral Agents; Cell Line; Cytomegalovirus; Drug Evaluation, Preclinical; Drug Synergism; Foscarnet; Guanine; Humans; Interferons; Mathematics; Phosphonoacetic Acid; Trifluridine; Viral Plaque Assay | 1982 |
Inhibition of reverse transcriptase activity of avian myeloblastosis virus by pyrophosphate analogues.
Topics: Avian Leukosis Virus; Avian Myeloblastosis Virus; Diphosphates; Diphosphonates; DNA Polymerase II; Foscarnet; Kinetics; Phosphonoacetic Acid; Polydeoxyribonucleotides; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 1982 |
Induction of alkaline phosphatase and the glycoprotein hormone alpha subunit in HeLa cells by inhibitors of DNA polymerase.
Topics: Alkaline Phosphatase; Aphidicolin; Cycloheximide; Dactinomycin; Diterpenes; DNA Polymerase II; DNA Replication; Enzyme Induction; Foscarnet; Glycoprotein Hormones, alpha Subunit; Glycoproteins; HeLa Cells; Hormones; Humans; Kinetics; Nucleic Acid Synthesis Inhibitors; Organophosphorus Compounds; Peptide Fragments; Phosphonoacetic Acid | 1982 |
Combined interaction of antiherpes substances and interferon beta on the multiplication of herpes simplex virus.
Topics: Acyclovir; Animals; Antiviral Agents; Arabinonucleosides; Cell Line; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Deoxyuridine; Drug Interactions; Foscarnet; Interferon Type I; Phosphonoacetic Acid; Simplexvirus; Tegafur; Thymidine; Vidarabine Phosphate | 1982 |
Combined chemotherapy of cutaneous herpes simplex infection of the guinea pig.
Topics: Acyclovir; Animals; Antiviral Agents; Arabinonucleosides; Deoxyuridine; Drug Therapy, Combination; Female; Foscarnet; Guinea Pigs; Herpes Simplex; Idoxuridine; Male; Phosphonoacetic Acid; Skin Diseases, Infectious; Thymidine; Trifluridine; Vidarabine Phosphate | 1983 |
Characterization of hepatitis B virus DNA polymerase.
Topics: Aphidicolin; Dideoxynucleotides; Diterpenes; DNA-Directed DNA Polymerase; Ethylmaleimide; Formaldehyde; Foscarnet; Hepatitis B virus; Hot Temperature; Nucleic Acid Synthesis Inhibitors; Phosphonoacetic Acid; Thymine Nucleotides; Vidarabine Phosphate; Virion | 1984 |
Effect of eight antiviral drugs on the reactivation of herpes simplex virus in explant cultures of latently infected mouse trigeminal ganglia.
Topics: Acyclovir; Animals; Antibodies, Viral; Antiviral Agents; Arabinofuranosyluracil; Arabinonucleosides; Bromodeoxyuridine; Culture Media; Culture Techniques; Cytarabine; Foscarnet; Mice; Mice, Hairless; Neutralization Tests; Phosphonoacetic Acid; Simplexvirus; Thymidine; Trigeminal Nerve; Vidarabine Phosphate; Virus Activation | 1984 |
Effects of foscarnet on the cell kinetics of Madin-Darby canine kidney cells.
Topics: Animals; Cell Cycle; Cell Division; Cell Line; DNA; Dogs; Foscarnet; Interphase; Kidney; Kinetics; Organophosphorus Compounds; Phosphonoacetic Acid | 1983 |
No in vivo effect of trisodium phosphonoformate on woodchuck hepatitis virus production.
Topics: Animals; DNA-Directed DNA Polymerase; Foscarnet; Hepatitis Viruses; Marmota; Organophosphorus Compounds; Phosphonoacetic Acid; Sciuridae | 1982 |
Phosphonoformic acid-inhibitable nucleotide incorporation as a measure of hepatitis B viral DNA polymerase activity.
Topics: Antiviral Agents; Biological Assay; Blood; Foscarnet; Hepatitis B virus; Humans; Nucleic Acid Synthesis Inhibitors; Nucleotides; Organophosphorus Compounds; Phosphonoacetic Acid; Virion | 1983 |
Micromethod for phosphonoformate inhibition assay of hepatitis B viral DNA polymerase.
Topics: Deoxycytosine Nucleotides; DNA-Directed DNA Polymerase; Foscarnet; Hepatitis B; Hepatitis B virus; Humans; Kinetics; Microchemistry; Nucleic Acid Synthesis Inhibitors; Organophosphorus Compounds; Phosphonoacetic Acid | 1984 |
Comparison of properties of woodchuck hepatitis virus and human hepatitis B virus endogenous DNA polymerases.
Topics: Animals; Antigens, Viral; Arabinonucleotides; DNA-Directed DNA Polymerase; Foscarnet; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis Viruses; Humans; Marmota; Nucleic Acid Synthesis Inhibitors; Phosphonoacetic Acid; Sciuridae; Species Specificity; Substrate Specificity | 1984 |
Mode of interference of trisodium phosphonoformate (INN: foscarnet sodium), with influenza virus mRNA synthesis.
Topics: Animals; Antiviral Agents; DNA-Directed RNA Polymerases; Foscarnet; Globins; Influenza A virus; Kinetics; Organophosphorus Compounds; Phosphonoacetic Acid; Phosphorus Radioisotopes; RNA, Messenger; Transcription, Genetic | 1984 |
Neuritic uptake and transport of antiviral drugs modifying herpes simplex virus infection of rat sensory neurons.
Topics: Acyclovir; Animals; Antigens, Viral; Biological Transport; Cells, Cultured; Female; Foscarnet; Ganglia, Spinal; Herpes Simplex; Nervous System Diseases; Neurons; Organophosphorus Compounds; Phosphonoacetic Acid; Pregnancy; Rats; Rats, Inbred Strains; Vidarabine; Virus Replication | 1984 |
In vitro recovery of resistant retrovirus isolates after exposure to phosphonoformate.
Topics: Animals; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Mice; Organophosphorus Compounds; Phosphonoacetic Acid; Retroviridae | 1984 |
Disseminating herpes simplex infection: primary lesions in urinary bladder and successful treatment with forscarnet sodium.
Topics: Adult; Female; Foscarnet; Herpes Simplex; Humans; Kidney Transplantation; Organophosphorus Compounds; Phosphonoacetic Acid; Urinary Bladder Diseases | 1984 |
Treatment of primary acute genital herpes in guinea pigs by intraperitoneal administration of fluoropyrimidines.
Topics: Acyclovir; Animals; Antiviral Agents; Arabinofuranosyluracil; Cytarabine; Female; Foscarnet; Guinea Pigs; Herpes Genitalis; Injections, Intraperitoneal; Male; Phosphonoacetic Acid; Uridine; Virus Replication | 1984 |
Studies on the biosynthesis of bialaphos (SF-1293). 4. Production of phosphonic acid derivatives, 2-hydroxyethylphosphonic acid, hydroxymethylphosphonic acid and phosphonoformic acid by blocked mutants of Streptomyces hygroscopicus SF-1293 and their roles
Topics: Anti-Bacterial Agents; Foscarnet; Herbicides; Mutation; Organophosphonates; Organophosphorus Compounds; Phosphonoacetic Acid; Streptomyces | 1984 |
Inhibition of cytomegalovirus late antigens by phosphonoformate.
Topics: Antigens, Viral; Cell Line; Cytomegalovirus; Cytopathogenic Effect, Viral; DNA-Directed DNA Polymerase; Dose-Response Relationship, Drug; Foscarnet; Humans; Organophosphorus Compounds; Phosphonoacetic Acid | 1980 |
Phosphonoformate inhibits synthesis of Epstein-Barr virus (EBV) capsid antigen and transformation of human cord blood lymphocytes by EBV.
Topics: Antigens, Viral; Capsid; Cell Line; Cell Transformation, Viral; Dose-Response Relationship, Drug; Foscarnet; Herpesvirus 4, Human; Humans; Lymphocyte Activation; Organophosphorus Compounds; Phosphonoacetic Acid | 1980 |
Effect of trisodium phosphonoformate and idoxuridine on experimental herpes simplex keratitis in immunized and non-immunized rabbits.
Topics: Animals; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Idoxuridine; Keratitis, Dendritic; Male; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus | 1980 |
Inhibition of herpesvirus multiplication in guinea pig skin by antiviral compounds.
Topics: Animals; Antiviral Agents; Cytarabine; Foscarnet; Guinea Pigs; Herpes Simplex; Idoxuridine; Male; Organophosphorus Compounds; Phosphonoacetic Acid; Ribavirin; Simplexvirus; Skin; Vidarabine; Virus Replication | 1980 |
Reversible inhibition of cytomegalovirus replication by phosphonoformate.
Topics: Animals; Antigens, Viral; Antiviral Agents; Cells, Cultured; Cricetinae; Cytomegalovirus; Foscarnet; Humans; Organophosphorus Compounds; Phosphonoacetic Acid; Viral Plaque Assay; Virus Replication | 1980 |
Mode of action of phosphonoformate as an anti-herpes simplex virus agent.
Topics: Antiviral Agents; Cell Division; Cell Nucleus; Cells, Cultured; DNA; DNA-Directed DNA Polymerase; Enzyme Induction; Foscarnet; HeLa Cells; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Time Factors; Virus Replication | 1981 |
The sensitivity of acyclovir-resistant mutants of herpes simplex virus to other antiviral drugs.
Topics: Acyclovir; Antiviral Agents; Arabinonucleosides; Bromodeoxyuridine; Drug Resistance, Microbial; Foscarnet; Guanine; Microbial Sensitivity Tests; Mutation; Phosphonoacetic Acid; Simplexvirus; Thymidine; Trifluridine; Vidarabine | 1981 |
Inhibitory effects of foscarnet on herpesvirus multiplication in cell culture.
Topics: Animals; Cell Line; Chlorocebus aethiops; Dose-Response Relationship, Drug; Foscarnet; Kidney; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Time Factors; Viral Plaque Assay; Virus Replication | 1981 |
Comparison of the effect of trisodium phosphonoformate on the mean plaque size of pseudorabies virus, infectious bovine rhinotracheitis virus and pigeon herpesvirus.
Topics: Animals; Cattle; Columbidae; Foscarnet; Herpesviridae; Herpesvirus 1, Suid; In Vitro Techniques; Organophosphorus Compounds; Phosphonoacetic Acid; Rhinovirus; Swine; Viral Plaque Assay | 1980 |
Mechanism of inhibition of Epstein-Barr virus replication by phosphonoformic acid.
Topics: Antigens, Viral; Antiviral Agents; Binding Sites; Cell Line; DNA-Directed DNA Polymerase; Enzyme Induction; Foscarnet; Herpesvirus 4, Human; Nucleic Acid Synthesis Inhibitors; Organophosphorus Compounds; Phosphonoacetic Acid; Virus Replication | 1981 |
Persistent reactivable latent herpes simplex virus infection in trigeminal ganglia of mice treated with antiviral drugs.
Topics: Acyclovir; Animals; Antiviral Agents; Foscarnet; Guanine; Herpes Simplex; Idoxuridine; Male; Mice; Mice, Inbred Strains; Phosphonoacetic Acid; Simplexvirus; Trigeminal Ganglion; Trigeminal Nerve; Vidarabine; Virus Replication | 1981 |
Chemotherapy of influenza and herpes virus infections.
Topics: Acyclovir; Amantadine; Antiviral Agents; Bromodeoxyuridine; Foscarnet; Guanine; Herpesviridae Infections; Humans; Influenza, Human; Phosphonoacetic Acid; Vidarabine | 1981 |
Multiplicity activation of herpes simplex virus in mouse neuroblastoma (C1300) cells.
Topics: Adsorption; Animals; Cell Line; Foscarnet; Idoxuridine; Mice; Mutation; Neuroblastoma; Neurons; Phosphonoacetic Acid; Simplexvirus; Viral Plaque Assay; Virus Activation | 1981 |
Therapeutic effects of foscarnet sodium and acyclovir on cutaneous infections due to herpes simplex virus type 1 in guinea pigs.
Topics: Acyclovir; Administration, Topical; Animals; Dose-Response Relationship, Drug; Foscarnet; Guanine; Guinea Pigs; Herpes Simplex; Ointments; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Skin Diseases | 1982 |
A comparison of phosphonoacetic acid and phosphonoformic acid activity in genital herpes simplex virus type 1 and type 2 infections of mice.
Topics: Animals; Antiviral Agents; Drug Evaluation, Preclinical; Female; Foscarnet; Ganglia, Spinal; Herpes Genitalis; Male; Mice; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Virus Replication | 1981 |
Structural factors influencing the ability of compounds to inhibit hydroxyapatite formation.
Topics: Adenosine Triphosphate; Calcium Phosphates; Citrates; Citric Acid; Durapatite; Etidronic Acid; Foscarnet; Glyceric Acids; Hydroxyapatites; Lasers; Magnesium; Nephelometry and Turbidimetry; Phosphates; Phosphonoacetic Acid; Structure-Activity Relationship | 1982 |
Assessment of phosphonoformate-treatment of pigeon herpesvirus infection in pigeons and budgerigars and Aujeszky's disease in rabbits.
Topics: Animals; Antiviral Agents; Bird Diseases; Birds; Columbidae; Foscarnet; Herpesviridae Infections; Organophosphorus Compounds; Phosphonoacetic Acid; Pseudorabies; Rabbits | 1982 |
Different in vitro effects of dual combinations of anti-herpes simplex virus compounds.
Topics: Acyclovir; Animals; Antiviral Agents; Bromodeoxyuridine; Cell Line; Chlorocebus aethiops; Drug Evaluation, Preclinical; Drug Interactions; Drug Synergism; Foscarnet; Guanine; Phosphonoacetic Acid; Simplexvirus; Trifluridine; Vidarabine | 1982 |
Characterization of the DNA polymerases induced by a group of herpes simplex virus type I variants selected for growth in the presence of phosphonoformic acid.
Topics: Antiviral Agents; DNA Replication; DNA-Directed DNA Polymerase; Foscarnet; Genetic Variation; Kinetics; Magnesium; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus | 1982 |
[Antiviral activity of phosphonoacetic acid, phosphonopropionic acid, and trisodium phosphonoformate hexahydrate against herpesvirus hominis type 1 and type 2 in vitro].
Topics: Animals; Antiviral Agents; Foscarnet; Humans; Organophosphonates; Organophosphorus Compounds; Phosphonoacetic Acid; Propionates; Rabbits; Simplexvirus; Viral Plaque Assay | 1982 |
Synergism among BIOLF-62, phosphonoformate, and other antiherpetic compounds.
Topics: Acyclovir; Antiviral Agents; Cells, Cultured; Drug Synergism; Foscarnet; Ganciclovir; Humans; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Viral Plaque Assay | 1982 |
Effect of phosphonoformate on symptomatic genital herpes simplex virus type 2 infection of guinea pigs.
Topics: Animals; Antiviral Agents; Drug Evaluation, Preclinical; Female; Foscarnet; Ganglia, Spinal; Guinea Pigs; Herpes Genitalis; Male; Organophosphorus Compounds; Phosphonoacetic Acid; Sciatic Nerve; Simplexvirus; Spinal Cord; Vagina | 1983 |
Synthesis of esters of phosphonoformic acid and their antiherpes activity.
Topics: Antiviral Agents; Esters; Foscarnet; Indicators and Reagents; Nucleic Acid Synthesis Inhibitors; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Structure-Activity Relationship; Viral Plaque Assay | 1983 |
Inhibition of human cytomegalovirus by trifluorothymidine.
Topics: Acyclovir; Cytomegalovirus; Foscarnet; Humans; Interferon Type I; Lung; Phosphonoacetic Acid; Thymidine; Trifluridine; Virus Replication | 1983 |
Susceptibility of phosphonoformic acid-resistant herpes simplex virus variants to arabinosylnucleosides and aphidicolin.
Topics: Antiviral Agents; Aphidicolin; Arabinonucleosides; Coformycin; Diterpenes; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Pentostatin; Phosphonoacetic Acid; Simplexvirus; Thymidine; Thymidine Kinase; Vidarabine | 1983 |
Effect of aphidicolin on DNA synthesis in HSV-1 infected and uninfected Vero cells.
Topics: Animals; Aphidicolin; Cell Line; Chlorocebus aethiops; Diterpenes; DNA; DNA, Viral; Foscarnet; Phosphonoacetic Acid; Simplexvirus | 1983 |
Effect of acyclovir and phosphonoformate on cytomegalovirus infection in guinea pigs.
Topics: Acyclovir; Animals; Antiviral Agents; Cytomegalovirus Infections; Disease Models, Animal; Foscarnet; Guinea Pigs; Infectious Mononucleosis; Liver; Lung; Organophosphorus Compounds; Phosphonoacetic Acid; Spleen | 1984 |
Synergistic antiviral effects of antiherpes compounds and human leukocyte interferon on varicella-zoster virus in vitro.
Topics: Acyclovir; Antiviral Agents; Bromodeoxyuridine; Drug Synergism; Foscarnet; Herpesvirus 3, Human; Humans; Interferon Type I; Microbial Sensitivity Tests; Phosphonoacetic Acid; Vidarabine | 1984 |
The potential of phosphonoformate for the treatment of herpex simplex labialis.
Topics: Antiviral Agents; Foscarnet; Herpes Labialis; Humans; Organophosphorus Compounds; Phosphonoacetic Acid | 1980 |
Trisodium phosphonoformate inhibits woodchuck hepatitis virus associated DNA polymerase.
Topics: Animals; Foscarnet; Hepatitis Viruses; Marmota; Nucleic Acid Synthesis Inhibitors; Organophosphorus Compounds; Phosphonoacetic Acid | 1980 |
In vitro inhibition of Herpesvirus sylvilagus by phosphonoacetic acid and phosphonoformate.
Topics: Dose-Response Relationship, Drug; Foscarnet; Herpesviridae; Organophosphorus Compounds; Phosphonoacetic Acid; Virus Replication | 1980 |
Inhibition of hepatitis-B-virus DNA polymerase by phosphonoformate: studies on its mode of action.
Topics: DNA-Directed DNA Polymerase; Foscarnet; Hepatitis B virus; Humans; Magnesium; Nucleic Acid Synthesis Inhibitors; Organophosphorus Compounds; Phosphonoacetic Acid | 1980 |
[Inhibition of hepatitis B virus associated DNA polymerase by antiviral agents: in vitro studies with clinical implications (author's transl)].
Topics: Antiviral Agents; Cytarabine; DNA, Viral; Foscarnet; Hepatitis B virus; Humans; Intercalating Agents; Nucleic Acid Synthesis Inhibitors; Phosphonoacetic Acid; Vidarabine | 1981 |
Suppression of infectious virus spread to the liver by foscarnet following lethal infection of acyclovir-resistant herpes simplex virus type 2 in mice.
Topics: Acyclovir; Animals; Arabinonucleosides; Brain; Chlorocebus aethiops; Drug Resistance, Microbial; Foscarnet; Hepatitis, Viral, Animal; Herpes Genitalis; Herpesvirus 2, Human; Humans; Injections, Intraperitoneal; Lethal Dose 50; Mice; Mice, Inbred C3H; Phosphonoacetic Acid; Thymidine; Vero Cells; Vidarabine | 1995 |
Synthesis and antiviral properties of sterol phosphonoformates.
Topics: Antiviral Agents; Cholesterol Esters; Culture Techniques; Foscarnet; HIV; Humans; Phosphonoacetic Acid; Reverse Transcriptase Inhibitors; Virus Replication | 1994 |
Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate- and phosphonoacetate-2',3'-dideoxy-3'-thiacytidine conjugates.
Topics: Antiviral Agents; Foscarnet; HIV-1; Lamivudine; Phosphonoacetic Acid; Prodrugs; Structure-Activity Relationship; Virus Replication; Zalcitabine | 1994 |
Bacteriophage T4 DNA polymerase mutations that confer sensitivity to the PPi analog phosphonoacetic acid.
Topics: Bacteriophage T4; Binding Sites; Dideoxynucleosides; Diphosphates; DNA Mutational Analysis; DNA Polymerase II; DNA Replication; DNA, Viral; Dose-Response Relationship, Drug; Foscarnet; Phosphonoacetic Acid; Structure-Activity Relationship | 1993 |
Lipid prodrugs of phosphonoacids: greatly enhanced antiviral activity of 1-O-octadecyl-sn-glycero-3-phosphonoformate in HIV-1, HSV-1 and HCMV-infected cells, in vitro.
Topics: Anti-HIV Agents; Antiviral Agents; Cell Line; Cytomegalovirus; DNA, Viral; Foscarnet; Herpesvirus 1, Human; HIV-1; Humans; Lipids; Phosphonoacetic Acid; Prodrugs | 1996 |
Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro.
Topics: Acyclovir; Adenine; Antiviral Agents; Cells, Cultured; Cidofovir; Cytarabine; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Fibroblasts; Foscarnet; Humans; Lung; Organophosphonates; Organophosphorus Compounds; Phosphonoacetic Acid | 1996 |
Effect of DNA synthesis inhibitors on Kaposi's sarcoma-associated herpesvirus cyclin and major capsid protein gene expression.
Topics: Blotting, Northern; Capsid; Carcinogens; Cyclins; Foscarnet; Gene Expression; Herpesvirus 8, Human; Humans; Nucleic Acid Synthesis Inhibitors; Phosphonoacetic Acid; RNA, Messenger; Tetradecanoylphorbol Acetate; Transcription, Genetic; Tumor Cells, Cultured | 1997 |
The effect of phosphate transporter inhibitors on the InsP3-induced Ca2+ release.
Topics: Animals; Calcium; Carrier Proteins; Cerebellum; Foscarnet; Inositol 1,4,5-Trisphosphate; Kinetics; Microsomes; Organophosphonates; Organophosphorus Compounds; Phosphate-Binding Proteins; Phosphonoacetic Acid; Rats | 1997 |
Uncharged AZT and D4T derivatives of phosphonoformic and phosphonoacetic acids as anti-HIV pronucleosides.
Topics: Anti-HIV Agents; Cell Line; Drug Stability; Foscarnet; HIV-1; Humans; Hydrolysis; Phosphonoacetic Acid; Prodrugs; Stavudine; Stereoisomerism; Structure-Activity Relationship; Zidovudine | 2004 |
DNA Analogues Modified at the Nonlinking Positions of Phosphorus.
Topics: Boranes; DNA; Foscarnet; Oligonucleotides; Organophosphonates; Organophosphorus Compounds; Phosphines; Phosphonoacetic Acid; Phosphorus | 2020 |